| | | | | | | | | | | | | | | | | | | | | |
<?xml version="1.0" encoding="windows-1252"?> |
<!-- XBRL Document Modified with Ez-Editor Version 1.0.6.8 on Tuesday, July 22, 2014 02:20:11 AM --> |
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"> |
| <roleRef xlink:type="simple" xlink:href="mrna-20121231.xsd#DocumentAndEntityInformation" roleURI="http://www.marinabiotech.com/role/DocumentAndEntityInformation"/> |
| <roleRef xlink:type="simple" xlink:href="mrna-20121231.xsd#ConsolidatedBalanceSheets" roleURI="http://www.marinabiotech.com/role/ConsolidatedBalanceSheets"/> |
| <roleRef xlink:type="simple" xlink:href="mrna-20121231.xsd#Consolidatedbalancesheetsparentheticals" roleURI="http://www.marinabiotech.com/role/Consolidatedbalancesheetsparentheticals"/> |
| <roleRef xlink:type="simple" xlink:href="mrna-20121231.xsd#ConsolidatedStatementsOfOperations" roleURI="http://www.marinabiotech.com/role/ConsolidatedStatementsOfOperations"/> |
| <roleRef xlink:type="simple" roleURI="http://www.marinabiotech.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT" xlink:href="mrna-20121231.xsd#CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"/> |
| <roleRef xlink:type="simple" xlink:href="mrna-20121231.xsd#ConsolidatedStatementsOfCashFlows" roleURI="http://www.marinabiotech.com/role/ConsolidatedStatementsOfCashFlows"/> |
| <roleRef xlink:type="simple" xlink:href="mrna-20121231.xsd#BusinessLiquidityAndSummaryOfSignificantAccountingPolicies" roleURI="http://www.marinabiotech.com/role/BusinessLiquidityAndSummaryOfSignificantAccountingPolicies"/> |
| <roleRef xlink:type="simple" xlink:href="mrna-20121231.xsd#LossOnImpairmentOfIntangibleAssets" roleURI="http://www.marinabiotech.com/role/LossOnImpairmentOfIntangibleAssets"/> |
| <roleRef xlink:type="simple" xlink:href="mrna-20121231.xsd#PropertyAndEquipment" roleURI="http://www.marinabiotech.com/role/PropertyAndEquipment"/> |
| <roleRef xlink:type="simple" xlink:href="mrna-20121231.xsd#RestructuringCharges" roleURI="http://www.marinabiotech.com/role/RestructuringCharges"/> |
| <roleRef xlink:type="simple" xlink:href="mrna-20121231.xsd#NotesPayable" roleURI="http://www.marinabiotech.com/role/NotesPayable"/> |
| <roleRef xlink:type="simple" xlink:href="mrna-20121231.xsd#StockholdersEquity" roleURI="http://www.marinabiotech.com/role/StockholdersEquity"/> |
| <roleRef xlink:type="simple" xlink:href="mrna-20121231.xsd#StockIncentivePlans" roleURI="http://www.marinabiotech.com/role/StockIncentivePlans"/> |
| <roleRef xlink:type="simple" xlink:href="mrna-20121231.xsd#EmployeeBenefitPlan" roleURI="http://www.marinabiotech.com/role/EmployeeBenefitPlan"/> |
| <roleRef xlink:type="simple" xlink:href="mrna-20121231.xsd#IncomeTaxes" roleURI="http://www.marinabiotech.com/role/IncomeTaxes"/> |
| <roleRef xlink:type="simple" xlink:href="mrna-20121231.xsd#IntellectualPropertyAndCollaborativeAgreements" roleURI="http://www.marinabiotech.com/role/IntellectualPropertyAndCollaborativeAgreements"/> |
| <roleRef xlink:type="simple" xlink:href="mrna-20121231.xsd#CommitmentsAndContingencies" roleURI="http://www.marinabiotech.com/role/CommitmentsAndContingencies"/> |
| <roleRef xlink:type="simple" xlink:href="mrna-20121231.xsd#BusinessLiquidityAndSummaryOfSignificantAccountingPoliciesPolicy" roleURI="http://www.marinabiotech.com/role/BusinessLiquidityAndSummaryOfSignificantAccountingPoliciesPolicy"/> |
| <roleRef xlink:type="simple" xlink:href="mrna-20121231.xsd#BusinessLiquidityAndSummaryOfSignificantAccountingPoliciesTables" roleURI="http://www.marinabiotech.com/role/BusinessLiquidityAndSummaryOfSignificantAccountingPoliciesTables"/> |
| <roleRef xlink:type="simple" xlink:href="mrna-20121231.xsd#PropertyandEquipmentTables" roleURI="http://www.marinabiotech.com/role/PropertyandEquipmentTables"/> |
| <roleRef xlink:type="simple" xlink:href="mrna-20121231.xsd#RestructuringChargesTables" roleURI="http://www.marinabiotech.com/role/RestructuringChargesTables"/> |
| <roleRef xlink:type="simple" xlink:href="mrna-20121231.xsd#StockholdersEquityTables" roleURI="http://www.marinabiotech.com/role/StockholdersEquityTables"/> |
| <roleRef xlink:type="simple" xlink:href="mrna-20121231.xsd#StockIncentivePlansTables" roleURI="http://www.marinabiotech.com/role/StockIncentivePlansTables"/> |
| <roleRef xlink:type="simple" xlink:href="mrna-20121231.xsd#IncomeTaxesTables" roleURI="http://www.marinabiotech.com/role/IncomeTaxesTables"/> |
| <roleRef xlink:type="simple" roleURI="http://www.marinabiotech.com/role/IntellectualPropertyAndCollaborativeAgreementsDetailTextuals" xlink:href="mrna-20121231.xsd#IntellectualPropertyAndCollaborativeAgreementsDetailTextuals"/> |
| <roleRef xlink:type="simple" roleURI="http://www.marinabiotech.com/role/IntellectualPropertyAndCollaborativeAgreementsDetailTextuals1" xlink:href="mrna-20121231.xsd#IntellectualPropertyAndCollaborativeAgreementsDetailTextuals1"/> |
| <roleRef xlink:type="simple" xlink:href="mrna-20121231.xsd#BusinessLiquidityAndSummaryOfSignificantAccountingPoliciesDetails" roleURI="http://www.marinabiotech.com/role/BusinessLiquidityAndSummaryOfSignificantAccountingPoliciesDetails"/> |
| <roleRef xlink:type="simple" xlink:href="mrna-20121231.xsd#BusinessLiquidityAndSummaryOfSignificantAccountingPoliciesDetails1" roleURI="http://www.marinabiotech.com/role/BusinessLiquidityAndSummaryOfSignificantAccountingPoliciesDetails1"/> |
| <roleRef xlink:type="simple" xlink:href="mrna-20121231.xsd#BusinessLiquidityAndSummaryOfSignificantAccountingPoliciesDetails2" roleURI="http://www.marinabiotech.com/role/BusinessLiquidityAndSummaryOfSignificantAccountingPoliciesDetails2"/> |
| <roleRef xlink:type="simple" xlink:href="mrna-20121231.xsd#BusinessLiquidityAndSummaryOfSignificantAccountingPoliciesDetails3" roleURI="http://www.marinabiotech.com/role/BusinessLiquidityAndSummaryOfSignificantAccountingPoliciesDetails3"/> |
| <roleRef xlink:type="simple" xlink:href="mrna-20121231.xsd#BusinessLiquidityAndSummaryOfSignificantAccountingPoliciesDetails4" roleURI="http://www.marinabiotech.com/role/BusinessLiquidityAndSummaryOfSignificantAccountingPoliciesDetails4"/> |
| <roleRef xlink:type="simple" xlink:href="mrna-20121231.xsd#BusinessLiquidityAndSummaryOfSignificantAccountingPoliciesDetails5" roleURI="http://www.marinabiotech.com/role/BusinessLiquidityAndSummaryOfSignificantAccountingPoliciesDetails5"/> |
| <roleRef xlink:type="simple" xlink:href="mrna-20121231.xsd#BusinessLiquidityAndSummaryOfSignificantAccountingPoliciesDetailTextuals" roleURI="http://www.marinabiotech.com/role/BusinessLiquidityAndSummaryOfSignificantAccountingPoliciesDetailTextuals"/> |
| <roleRef xlink:type="simple" xlink:href="mrna-20121231.xsd#LossOnImpairmentOfIntangibleAssetsDetailTextuals" roleURI="http://www.marinabiotech.com/role/LossOnImpairmentOfIntangibleAssetsDetailTextuals"/> |
| <roleRef xlink:type="simple" xlink:href="mrna-20121231.xsd#LossOnImpairmentOfIntangibleAssetsDetailTextuals1" roleURI="http://www.marinabiotech.com/role/LossOnImpairmentOfIntangibleAssetsDetailTextuals1"/> |
| <roleRef xlink:type="simple" xlink:href="mrna-20121231.xsd#PropertyandEquipmentDetails" roleURI="http://www.marinabiotech.com/role/PropertyandEquipmentDetails"/> |
| <roleRef xlink:type="simple" xlink:href="mrna-20121231.xsd#PropertyAndEquipmentDetailTextuals" roleURI="http://www.marinabiotech.com/role/PropertyAndEquipmentDetailTextuals"/> |
| <roleRef xlink:type="simple" xlink:href="mrna-20121231.xsd#RestructuringChargesDetails" roleURI="http://www.marinabiotech.com/role/RestructuringChargesDetails"/> |
| <roleRef xlink:type="simple" xlink:href="mrna-20121231.xsd#RestructuringChargesDetailTextuals" roleURI="http://www.marinabiotech.com/role/RestructuringChargesDetailTextuals"/> |
| <roleRef xlink:type="simple" xlink:href="mrna-20121231.xsd#NotesPayableDetailTextuals" roleURI="http://www.marinabiotech.com/role/NotesPayableDetailTextuals"/> |
| <roleRef xlink:type="simple" xlink:href="mrna-20121231.xsd#NotesPayableDetailTextuals1" roleURI="http://www.marinabiotech.com/role/NotesPayableDetailTextuals1"/> |
| <roleRef xlink:type="simple" xlink:href="mrna-20121231.xsd#StockholdersEquityDetails" roleURI="http://www.marinabiotech.com/role/StockholdersEquityDetails"/> |
| <roleRef xlink:type="simple" xlink:href="mrna-20121231.xsd#StockholdersEquityDetails1" roleURI="http://www.marinabiotech.com/role/StockholdersEquityDetails1"/> |
| <roleRef xlink:type="simple" xlink:href="mrna-20121231.xsd#StockholdersEquityPreferredStockDetails" roleURI="http://www.marinabiotech.com/role/StockholdersEquityPreferredStockDetails"/> |
| <roleRef xlink:type="simple" xlink:href="mrna-20121231.xsd#StockholdersEquityCommonStockDetails" roleURI="http://www.marinabiotech.com/role/StockholdersEquityCommonStockDetails"/> |
| <roleRef xlink:type="simple" xlink:href="mrna-20121231.xsd#StockholdersEquityWarrantsDetails" roleURI="http://www.marinabiotech.com/role/StockholdersEquityWarrantsDetails"/> |
| <roleRef xlink:type="simple" xlink:href="mrna-20121231.xsd#StockholdersEquitySubscriptionInvestmentUnitsDetails" roleURI="http://www.marinabiotech.com/role/StockholdersEquitySubscriptionInvestmentUnitsDetails"/> |
| <roleRef xlink:type="simple" roleURI="http://www.marinabiotech.com/role/StockIncentivePlansDetailTextuals" xlink:href="mrna-20121231.xsd#StockIncentivePlansDetailTextuals"/> |
| <roleRef xlink:type="simple" roleURI="http://www.marinabiotech.com/role/StockIncentivePlansStockBasedCompensationExpenseDetails" xlink:href="mrna-20121231.xsd#StockIncentivePlansStockBasedCompensationExpenseDetails"/> |
| <roleRef xlink:type="simple" roleURI="http://www.marinabiotech.com/role/StockIncentivePlansStockOptionActivityDetails" xlink:href="mrna-20121231.xsd#StockIncentivePlansStockOptionActivityDetails"/> |
| <roleRef xlink:type="simple" roleURI="http://www.marinabiotech.com/role/StockIncentivePlansStockOptionsOutstandingDetails" xlink:href="mrna-20121231.xsd#StockIncentivePlansStockOptionsOutstandingDetails"/> |
| <roleRef xlink:type="simple" roleURI="http://www.marinabiotech.com/role/StockIncentivePlansWeightedAverageAssumptionsDetails" xlink:href="mrna-20121231.xsd#StockIncentivePlansWeightedAverageAssumptionsDetails"/> |
| <roleRef xlink:type="simple" xlink:href="mrna-20121231.xsd#EmployeeBenefitPlanDetailTextuals" roleURI="http://www.marinabiotech.com/role/EmployeeBenefitPlanDetailTextuals"/> |
| <roleRef xlink:type="simple" xlink:href="mrna-20121231.xsd#IncomeTaxesDetails" roleURI="http://www.marinabiotech.com/role/IncomeTaxesDetails"/> |
| <roleRef xlink:type="simple" xlink:href="mrna-20121231.xsd#IncomeTaxesDetailTextuals" roleURI="http://www.marinabiotech.com/role/IncomeTaxesDetailTextuals"/> |
| <roleRef xlink:type="simple" xlink:href="mrna-20121231.xsd#CommitmentsAndContingenciesDetails" roleURI="http://www.marinabiotech.com/role/CommitmentsAndContingenciesDetails"/> |
| <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/> |
| <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/> |
| <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/> |
| <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/> |
| <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel"/> |
| <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/> |
| <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel"/> |
| <presentationLink xlink:type="extended" xlink:role="http://www.marinabiotech.com/role/DocumentAndEntityInformation"> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_DocumentAndEntityInformationAbstract" xlink:label="loc_mrna_DocumentAndEntityInformationAbstract_0"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_1"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_EntityRegistrantName_1" order="0" use="optional"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_2"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_EntityCentralIndexKey_2" order="10" use="optional"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_3"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_TradingSymbol_3" order="20" use="optional"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_dei_EntityCurrentReportingStatus_4"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_EntityCurrentReportingStatus_4" order="30" use="optional"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_dei_EntityVoluntaryFilers_5"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_EntityVoluntaryFilers_5" order="40" use="optional"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_6"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_CurrentFiscalYearEndDate_6" order="50" use="optional"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_7"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_EntityFilerCategory_7" order="60" use="optional"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_8"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_8" order="70" use="optional"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_9"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_9" order="80" use="optional"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityPublicFloat" xlink:label="loc_dei_EntityPublicFloat_10"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_EntityPublicFloat_10" order="90" use="optional"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_11"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_DocumentType_11" order="100" use="optional"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_12"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_DocumentPeriodEndDate_12" order="110" use="optional"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_13"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_AmendmentFlag_13" order="120" use="optional"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_14"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_DocumentFiscalYearFocus_14" order="130" use="optional"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_15"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_DocumentFiscalPeriodFocus_15" order="140" use="optional"/> |
| | </presentationLink> |
| <presentationLink xlink:type="extended" xlink:role="http://www.marinabiotech.com/role/ConsolidatedBalanceSheets"> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_0"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_1"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_AssetsAbstract_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract_2"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1" xlink:to="loc_us-gaap_AssetsCurrentAbstract_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_2" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_4"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_2" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_5"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_2" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_5" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_6"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_2" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_6" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_7"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_2" xlink:to="loc_us-gaap_AssetsCurrent_7" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_8"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_9"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_10"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_10" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_11"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1" xlink:to="loc_us-gaap_Assets_11" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_12"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_12" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_13"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_12" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_13" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_14"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_13" xlink:to="loc_us-gaap_AccountsPayableCurrent_14" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_15"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_13" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_15" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_16"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_13" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_16" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_17"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_13" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_17" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_AccruedRestructuringCost" xlink:label="loc_mrna_AccruedRestructuringCost_18"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_13" xlink:to="loc_mrna_AccruedRestructuringCost_18" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaap_NotesPayableCurrent_19"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_13" xlink:to="loc_us-gaap_NotesPayableCurrent_19" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherShortTermBorrowings" xlink:label="loc_us-gaap_OtherShortTermBorrowings_20"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_13" xlink:to="loc_us-gaap_OtherShortTermBorrowings_20" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaap_DeferredRevenueCurrent_21"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_13" xlink:to="loc_us-gaap_DeferredRevenueCurrent_21" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_22"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_13" xlink:to="loc_us-gaap_LiabilitiesCurrent_22" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_DeferredRentAndOtherLongTermLiabilities" xlink:label="loc_mrna_DeferredRentAndOtherLongTermLiabilities_23"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_12" xlink:to="loc_mrna_DeferredRentAndOtherLongTermLiabilities_23" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_FairValueLiabilityForPriceAdjustableSubscriptionInvestmentUnits" xlink:label="loc_mrna_FairValueLiabilityForPriceAdjustableSubscriptionInvestmentUnits_24"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_12" xlink:to="loc_mrna_FairValueLiabilityForPriceAdjustableSubscriptionInvestmentUnits_24" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_FairValueLiabilityForPriceAdjustableWarrants" xlink:label="loc_mrna_FairValueLiabilityForPriceAdjustableWarrants_25"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_12" xlink:to="loc_mrna_FairValueLiabilityForPriceAdjustableWarrants_25" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_FairValueOfStockToBeIssuedToSettleLiabilities" xlink:label="loc_mrna_FairValueOfStockToBeIssuedToSettleLiabilities_26"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_12" xlink:to="loc_mrna_FairValueOfStockToBeIssuedToSettleLiabilities_26" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesNoncurrent_27"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_12" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesNoncurrent_27" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_28"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_12" xlink:to="loc_us-gaap_Liabilities_28" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies_29"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_12" xlink:to="loc_us-gaap_CommitmentsAndContingencies_29" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaap_StockholdersEquityAbstract_30"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_12" xlink:to="loc_us-gaap_StockholdersEquityAbstract_30" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaap_PreferredStockValue_31"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_30" xlink:to="loc_us-gaap_PreferredStockValue_31" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStocksIncludingAdditionalPaidInCapital" xlink:label="loc_us-gaap_CommonStocksIncludingAdditionalPaidInCapital_32"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_30" xlink:to="loc_us-gaap_CommonStocksIncludingAdditionalPaidInCapital_32" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_33"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_30" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_33" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_34"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_30" xlink:to="loc_us-gaap_StockholdersEquity_34" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_35"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_12" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_35" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/> |
| | </presentationLink> |
| <presentationLink xlink:type="extended" xlink:role="http://www.marinabiotech.com/role/Consolidatedbalancesheetsparentheticals"> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_0"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_1"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_1" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_2"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_2" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_5"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_5" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_6"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_6" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_7"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_CommonStockSharesIssued_7" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_8"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_8" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaap_PreferredStockSharesIssued"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_PreferredStockSharesIssued" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | </presentationLink> |
| <presentationLink xlink:type="extended" xlink:role="http://www.marinabiotech.com/role/ConsolidatedStatementsOfOperations"> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract_0"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LicenseAndServicesRevenue" xlink:label="loc_us-gaap_LicenseAndServicesRevenue_1"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_LicenseAndServicesRevenue_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaap_OperatingExpensesAbstract_2"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_OperatingExpensesAbstract_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_3"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_2" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_4"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_2" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_5"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_2" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_5" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="loc_us-gaap_RestructuringCharges_6"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_2" xlink:to="loc_us-gaap_RestructuringCharges_6" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_7"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_2" xlink:to="loc_us-gaap_OperatingExpenses_7" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_8"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_OperatingIncomeLoss_8" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_9"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_9" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_InterestAndOtherExpense" xlink:label="loc_mrna_InterestAndOtherExpense_11"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_9" xlink:to="loc_mrna_InterestAndOtherExpense_11" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_FairValueAdjustmentOfPriceAdjustableWarrantsAndSubscriptionInvestmentUnits" xlink:label="loc_mrna_FairValueAdjustmentOfPriceAdjustableWarrantsAndSubscriptionInvestmentUnits_12"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_9" xlink:to="loc_mrna_FairValueAdjustmentOfPriceAdjustableWarrantsAndSubscriptionInvestmentUnits_12" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_GainLossOnSettlementOfLiabilities" xlink:label="loc_mrna_GainLossOnSettlementOfLiabilities_13"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_9" xlink:to="loc_mrna_GainLossOnSettlementOfLiabilities_13" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_ChangeInFairValueOfStockReservedForIssuanceToSettleLiabilities" xlink:label="loc_mrna_ChangeInFairValueOfStockReservedForIssuanceToSettleLiabilities_14"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_9" xlink:to="loc_mrna_ChangeInFairValueOfStockReservedForIssuanceToSettleLiabilities_14" order="40" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet" xlink:label="loc_us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_15"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_9" xlink:to="loc_us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_15" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_16"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_9" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_16" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_17"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_9" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_17" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_18"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_18" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_19"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_19" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_20"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_NetIncomeLoss_20" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDiluted_21"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDiluted_21" order="70" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_22"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_22" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_NonCashFinancingCosts" xlink:label="loc_mrna_NonCashFinancingCosts"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_9" xlink:to="loc_mrna_NonCashFinancingCosts" order="60" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/> |
| | </presentationLink> |
| <presentationLink xlink:type="extended" xlink:role="http://www.marinabiotech.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_0"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_0" xlink:to="loc_us-gaap_StatementTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_2"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember_3"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2" xlink:to="loc_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_4"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2" xlink:to="loc_us-gaap_RetainedEarningsMember_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_5"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2" xlink:to="loc_us-gaap_EquityComponentDomain_5" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_6"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementLineItems_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="loc_us-gaap_StockholdersEquity" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="loc_us-gaap_CommonStockSharesOutstanding" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodShares" xlink:label="loc_us-gaap_StockRedeemedOrCalledDuringPeriodShares"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="loc_us-gaap_StockRedeemedOrCalledDuringPeriodShares" order="4" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_SharesIssuedInConnectionWithTerminationOfLease" xlink:label="loc_mrna_SharesIssuedInConnectionWithTerminationOfLease"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="loc_mrna_SharesIssuedInConnectionWithTerminationOfLease" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_SharesIssuedInConnectionWithTerminationOfLeaseShares" xlink:label="loc_mrna_SharesIssuedInConnectionWithTerminationOfLeaseShares"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="loc_mrna_SharesIssuedInConnectionWithTerminationOfLeaseShares" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_ProceedsFromExerciseOfSubscriptionInvestmentUnitsAndWarrants" xlink:label="loc_mrna_ProceedsFromExerciseOfSubscriptionInvestmentUnitsAndWarrants"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="loc_mrna_ProceedsFromExerciseOfSubscriptionInvestmentUnitsAndWarrants" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_ProceedsFromExerciseOfSubscriptionInvestmentUnitsAndWarrantsShares" xlink:label="loc_mrna_ProceedsFromExerciseOfSubscriptionInvestmentUnitsAndWarrantsShares"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="loc_mrna_ProceedsFromExerciseOfSubscriptionInvestmentUnitsAndWarrantsShares" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_ReclassificationOfFairValueOfPriceAdjustableSubscriptionInvestmentUnitsAndWarrantsFromLiabilityToEquityUponExercise" xlink:label="loc_mrna_ReclassificationOfFairValueOfPriceAdjustableSubscriptionInvestmentUnitsAndWarrantsFromLiabilityToEquityUponExercise"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="loc_mrna_ReclassificationOfFairValueOfPriceAdjustableSubscriptionInvestmentUnitsAndWarrantsFromLiabilityToEquityUponExercise" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_ReclassificationOfFairValueForPriceAdjustableWarrantsFromLiabilityToEquityUponEliminationOfPriceAdjustmentFeature" xlink:label="loc_mrna_ReclassificationOfFairValueForPriceAdjustableWarrantsFromLiabilityToEquityUponEliminationOfPriceAdjustmentFeature"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="loc_mrna_ReclassificationOfFairValueForPriceAdjustableWarrantsFromLiabilityToEquityUponEliminationOfPriceAdjustmentFeature" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" order="13" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" order="14" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_ReclassificationOfFairValueLiabilityForPriceAdjustableWarrantsExercised" xlink:label="loc_mrna_ReclassificationOfFairValueLiabilityForPriceAdjustableWarrantsExercised"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="loc_mrna_ReclassificationOfFairValueLiabilityForPriceAdjustableWarrantsExercised" order="15" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_ReclassificationOfFairValueLiabilityForPriceAdjustableWarrantsExercisedShares" xlink:label="loc_mrna_ReclassificationOfFairValueLiabilityForPriceAdjustableWarrantsExercisedShares"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="loc_mrna_ReclassificationOfFairValueLiabilityForPriceAdjustableWarrantsExercisedShares" order="16" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentAmount1"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentAmount1" order="17" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" order="18" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" order="19" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognitionShares" xlink:label="loc_mrna_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognitionShares"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="loc_mrna_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognitionShares" order="21" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="loc_us-gaap_NetIncomeLoss" order="22" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_1"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="loc_us-gaap_StockholdersEquity_1" order="23" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_1"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_1" order="24" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/> |
| | </presentationLink> |
| <presentationLink xlink:type="extended" xlink:role="http://www.marinabiotech.com/role/ConsolidatedStatementsOfCashFlows"> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_0"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_1"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_2"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_1" xlink:to="loc_us-gaap_NetIncomeLoss_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_1" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_4"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3" xlink:to="loc_us-gaap_ShareBasedCompensation_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_5"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_5" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_6"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_6" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_7"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_7" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherNoncashExpense" xlink:label="loc_us-gaap_OtherNoncashExpense_8"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3" xlink:to="loc_us-gaap_OtherNoncashExpense_8" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccretionExpense" xlink:label="loc_us-gaap_AccretionExpense_9"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3" xlink:to="loc_us-gaap_AccretionExpense_9" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_10"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_10" order="70" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RestructuringCosts" xlink:label="loc_us-gaap_RestructuringCosts_11"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3" xlink:to="loc_us-gaap_RestructuringCosts_11" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_NonCashGainOnSettlementOfLiabilities" xlink:label="loc_mrna_NonCashGainOnSettlementOfLiabilities_12"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3" xlink:to="loc_mrna_NonCashGainOnSettlementOfLiabilities_12" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_14"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_14" order="90" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_NonCashInterestExpense" xlink:label="loc_mrna_NonCashInterestExpense_15"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3" xlink:to="loc_mrna_NonCashInterestExpense_15" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_ChangesInFairMarketValueOfLiabilitiesAbstract" xlink:label="loc_mrna_ChangesInFairMarketValueOfLiabilitiesAbstract_16"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3" xlink:to="loc_mrna_ChangesInFairMarketValueOfLiabilitiesAbstract_16" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_17"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_ChangesInFairMarketValueOfLiabilitiesAbstract_16" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_17" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_ChangeInFairValueOfStockReservedForIssuanceToSettleLiabilities" xlink:label="loc_mrna_ChangeInFairValueOfStockReservedForIssuanceToSettleLiabilities_18"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_ChangesInFairMarketValueOfLiabilitiesAbstract_16" xlink:to="loc_mrna_ChangeInFairValueOfStockReservedForIssuanceToSettleLiabilities_18" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet" xlink:label="loc_us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_19"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_ChangesInFairMarketValueOfLiabilitiesAbstract_16" xlink:to="loc_us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_19" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_20"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_20" order="150" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_21"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_20" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_21" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_22"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_20" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_22" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_23"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_20" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_23" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_24"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_20" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_24" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_IncreaseDecreaseInDeferredRent" xlink:label="loc_mrna_IncreaseDecreaseInDeferredRent_25"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_20" xlink:to="loc_mrna_IncreaseDecreaseInDeferredRent_25" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_26"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_20" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_26" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_IncreaseDecreaseInAccruedRestructuring" xlink:label="loc_mrna_IncreaseDecreaseInAccruedRestructuring_27"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_20" xlink:to="loc_mrna_IncreaseDecreaseInAccruedRestructuring_27" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_29"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_29" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_30"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_30" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_31"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_30" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_31" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInRestrictedCash" xlink:label="loc_us-gaap_IncreaseDecreaseInRestrictedCash_32"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_30" xlink:to="loc_us-gaap_IncreaseDecreaseInRestrictedCash_32" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_33"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_30" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_33" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_34"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_30" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_34" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_35"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_35" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_36"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_35" xlink:to="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_36" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_37"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_35" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_37" order="30" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_ProceedsFrpmNetInsuranceFinancing" xlink:label="loc_mrna_ProceedsFrpmNetInsuranceFinancing_38"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_35" xlink:to="loc_mrna_ProceedsFrpmNetInsuranceFinancing_38" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_41"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_35" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_41" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_42"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_35" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_42" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashPeriodIncreaseDecrease" xlink:label="loc_us-gaap_CashPeriodIncreaseDecrease_43"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_CashPeriodIncreaseDecrease_43" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_44"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_44" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_45"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_45" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_46"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_46" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_48"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_48" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InterestPaid" xlink:label="loc_us-gaap_InterestPaid_49"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_48" xlink:to="loc_us-gaap_InterestPaid_49" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_NonCashFinancingCosts" xlink:label="loc_mrna_NonCashFinancingCosts"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3" xlink:to="loc_mrna_NonCashFinancingCosts" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_ProceedsFromIssuanceOfNotesPayableAndWarrants" xlink:label="loc_mrna_ProceedsFromIssuanceOfNotesPayableAndWarrants"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_35" xlink:to="loc_mrna_ProceedsFromIssuanceOfNotesPayableAndWarrants" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_NonCashFinancingReclassificationOfFairValueLiabilityForPriceAdjustableWarrantsExercised" xlink:label="loc_mrna_NonCashFinancingReclassificationOfFairValueLiabilityForPriceAdjustableWarrantsExercised"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_46" xlink:to="loc_mrna_NonCashFinancingReclassificationOfFairValueLiabilityForPriceAdjustableWarrantsExercised" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssued1" xlink:label="loc_us-gaap_StockIssued1"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_46" xlink:to="loc_us-gaap_StockIssued1" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | </presentationLink> |
| <presentationLink xlink:type="extended" xlink:role="http://www.marinabiotech.com/role/BusinessLiquidityAndSummaryOfSignificantAccountingPolicies"> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_1"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | </presentationLink> |
| <presentationLink xlink:type="extended" xlink:role="http://www.marinabiotech.com/role/LossOnImpairmentOfIntangibleAssets"> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_0"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_1"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_0" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | </presentationLink> |
| <presentationLink xlink:type="extended" xlink:role="http://www.marinabiotech.com/role/PropertyAndEquipment"> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_1"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | </presentationLink> |
| <presentationLink xlink:type="extended" xlink:role="http://www.marinabiotech.com/role/RestructuringCharges"> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RestructuringChargesAbstract" xlink:label="loc_us-gaap_RestructuringChargesAbstract_0"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_1"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringChargesAbstract_0" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | </presentationLink> |
| <presentationLink xlink:type="extended" xlink:role="http://www.marinabiotech.com/role/NotesPayable"> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongTermDebtOtherDisclosuresAbstract" xlink:label="loc_us-gaap_LongTermDebtOtherDisclosuresAbstract_0"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongTermDebtTextBlock" xlink:label="loc_us-gaap_LongTermDebtTextBlock_1"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtOtherDisclosuresAbstract_0" xlink:to="loc_us-gaap_LongTermDebtTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | </presentationLink> |
| <presentationLink xlink:type="extended" xlink:role="http://www.marinabiotech.com/role/StockholdersEquity"> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_0"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_1"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | </presentationLink> |
| <presentationLink xlink:type="extended" xlink:role="http://www.marinabiotech.com/role/StockIncentivePlans"> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_1"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | </presentationLink> |
| <presentationLink xlink:type="extended" xlink:role="http://www.marinabiotech.com/role/EmployeeBenefitPlan"> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_0"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:label="loc_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_1"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_0" xlink:to="loc_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | </presentationLink> |
| <presentationLink xlink:type="extended" xlink:role="http://www.marinabiotech.com/role/IncomeTaxes"> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_1"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | </presentationLink> |
| <presentationLink xlink:type="extended" xlink:role="http://www.marinabiotech.com/role/IntellectualPropertyAndCollaborativeAgreements"> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_IntellectualPropertyAndContractualAgreementsAbstract" xlink:label="loc_mrna_IntellectualPropertyAndContractualAgreementsAbstract_0"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_IntellectualPropertyAndContractualAgreementsDisclosureTextBlock" xlink:label="loc_mrna_IntellectualPropertyAndContractualAgreementsDisclosureTextBlock_1"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_IntellectualPropertyAndContractualAgreementsAbstract_0" xlink:to="loc_mrna_IntellectualPropertyAndContractualAgreementsDisclosureTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | </presentationLink> |
| <presentationLink xlink:type="extended" xlink:role="http://www.marinabiotech.com/role/CommitmentsAndContingencies"> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_1"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | </presentationLink> |
| <presentationLink xlink:type="extended" xlink:role="http://www.marinabiotech.com/role/BusinessLiquidityAndSummaryOfSignificantAccountingPoliciesPolicy"> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_1"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaap_UseOfEstimates_2"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_UseOfEstimates_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_3"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_4"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_5"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_6"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:label="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_7"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_8"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_8" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock_9"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_RevenueRecognitionPolicyTextBlock_9" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_10"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_10" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_11"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_11" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_12"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_12" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LeasePolicyTextBlock" xlink:label="loc_us-gaap_LeasePolicyTextBlock_13"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_LeasePolicyTextBlock_13" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_NotesPayablePolicyTextBlock" xlink:label="loc_mrna_NotesPayablePolicyTextBlock_14"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_mrna_NotesPayablePolicyTextBlock_14" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_15"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_15" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | </presentationLink> |
| <presentationLink xlink:type="extended" xlink:role="http://www.marinabiotech.com/role/BusinessLiquidityAndSummaryOfSignificantAccountingPoliciesTables"> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_1"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_2"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueInputsLiabilitiesQuantitativeInformationTableTextBlock" xlink:label="loc_us-gaap_FairValueInputsLiabilitiesQuantitativeInformationTableTextBlock_3"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0" xlink:to="loc_us-gaap_FairValueInputsLiabilitiesQuantitativeInformationTableTextBlock_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_ScheduleOfFairValueMeasurementOfPriceAdjustableWarrantsDeterminedByLevelThreeTableTextBlock" xlink:label="loc_mrna_ScheduleOfFairValueMeasurementOfPriceAdjustableWarrantsDeterminedByLevelThreeTableTextBlock_4"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0" xlink:to="loc_mrna_ScheduleOfFairValueMeasurementOfPriceAdjustableWarrantsDeterminedByLevelThreeTableTextBlock_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_5"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_6"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | </presentationLink> |
| <presentationLink xlink:type="extended" xlink:role="http://www.marinabiotech.com/role/PropertyandEquipmentTables"> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_1"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | </presentationLink> |
| <presentationLink xlink:type="extended" xlink:role="http://www.marinabiotech.com/role/RestructuringChargesTables"> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RestructuringChargesAbstract" xlink:label="loc_us-gaap_RestructuringChargesAbstract_0"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_1"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringChargesAbstract_0" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | </presentationLink> |
| <presentationLink xlink:type="extended" xlink:role="http://www.marinabiotech.com/role/StockholdersEquityTables"> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_0"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_1"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_ScheduleOfSubscriptionInvestmentUnitActivityTableTextBlock" xlink:label="loc_mrna_ScheduleOfSubscriptionInvestmentUnitActivityTableTextBlock_2"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_mrna_ScheduleOfSubscriptionInvestmentUnitActivityTableTextBlock_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | </presentationLink> |
| <presentationLink xlink:type="extended" xlink:role="http://www.marinabiotech.com/role/StockIncentivePlansTables"> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_1"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_2"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock_3"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_4"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | </presentationLink> |
| <presentationLink xlink:type="extended" xlink:role="http://www.marinabiotech.com/role/IncomeTaxesTables"> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_1"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | </presentationLink> |
| <presentationLink xlink:type="extended" xlink:role="http://www.marinabiotech.com/role/IntellectualPropertyAndCollaborativeAgreementsDetailTextuals"> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_IntellectualPropertyAndContractualAgreementsAbstract" xlink:label="loc_mrna_IntellectualPropertyAndContractualAgreementsAbstract_0"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_IntellectualPropertyAndCollaborativeAgreementsTable" xlink:label="loc_mrna_IntellectualPropertyAndCollaborativeAgreementsTable_1"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_IntellectualPropertyAndContractualAgreementsAbstract_0" xlink:to="loc_mrna_IntellectualPropertyAndCollaborativeAgreementsTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_2"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_IntellectualPropertyAndCollaborativeAgreementsTable_1" xlink:to="loc_dei_LegalEntityAxis_2" order="0" use="optional"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_3"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_2" xlink:to="loc_dei_EntityDomain_3" order="0" use="optional"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_ArcturusMember" xlink:label="loc_mrna_ArcturusMember_4"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_3" xlink:to="loc_mrna_ArcturusMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_TekmiraMember" xlink:label="loc_mrna_TekmiraMember_5"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_3" xlink:to="loc_mrna_TekmiraMember_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_NovartisMember" xlink:label="loc_mrna_NovartisMember_6"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_3" xlink:to="loc_mrna_NovartisMember_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_MonsantoMember" xlink:label="loc_mrna_MonsantoMember_7"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_3" xlink:to="loc_mrna_MonsantoMember_7" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_PronaiTherapeuticsIncMember" xlink:label="loc_mrna_PronaiTherapeuticsIncMember_8"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_3" xlink:to="loc_mrna_PronaiTherapeuticsIncMember_8" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_MirnaTherapeuticsMember" xlink:label="loc_mrna_MirnaTherapeuticsMember_9"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_3" xlink:to="loc_mrna_MirnaTherapeuticsMember_9" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_11"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_IntellectualPropertyAndCollaborativeAgreementsTable_1" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_11" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_12"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_11" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_12" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_13"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_12" xlink:to="loc_us-gaap_SubsequentEventMember_13" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_IntellectualPropertyAndCollaborativeAgreementsLineItems" xlink:label="loc_mrna_IntellectualPropertyAndCollaborativeAgreementsLineItems_14"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_IntellectualPropertyAndCollaborativeAgreementsTable_1" xlink:to="loc_mrna_IntellectualPropertyAndCollaborativeAgreementsLineItems_14" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromLicenseFeesReceived" xlink:label="loc_us-gaap_ProceedsFromLicenseFeesReceived_15"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_IntellectualPropertyAndCollaborativeAgreementsLineItems_14" xlink:to="loc_us-gaap_ProceedsFromLicenseFeesReceived_15" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_UpfrontPaymentReceived" xlink:label="loc_mrna_UpfrontPaymentReceived_16"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_IntellectualPropertyAndCollaborativeAgreementsLineItems_14" xlink:to="loc_mrna_UpfrontPaymentReceived_16" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_AdditionalPaymentReceivedUnderLicenseAgreement" xlink:label="loc_mrna_AdditionalPaymentReceivedUnderLicenseAgreement_17"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_IntellectualPropertyAndCollaborativeAgreementsLineItems_14" xlink:to="loc_mrna_AdditionalPaymentReceivedUnderLicenseAgreement_17" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_FutureAdditionalUpfrontPayment" xlink:label="loc_mrna_FutureAdditionalUpfrontPayment_18"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_IntellectualPropertyAndCollaborativeAgreementsLineItems_14" xlink:to="loc_mrna_FutureAdditionalUpfrontPayment_18" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_ReductionOfFeesInExchangeForAcceleratedPayment" xlink:label="loc_mrna_ReductionOfFeesInExchangeForAcceleratedPayment_19"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_IntellectualPropertyAndCollaborativeAgreementsLineItems_14" xlink:to="loc_mrna_ReductionOfFeesInExchangeForAcceleratedPayment_19" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_PhaseOneClinicalDevelopmentMilestone" xlink:label="loc_mrna_PhaseOneClinicalDevelopmentMilestone_20"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_IntellectualPropertyAndCollaborativeAgreementsLineItems_14" xlink:to="loc_mrna_PhaseOneClinicalDevelopmentMilestone_20" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_NumberOfCompounds" xlink:label="loc_mrna_NumberOfCompounds_21"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_IntellectualPropertyAndCollaborativeAgreementsLineItems_14" xlink:to="loc_mrna_NumberOfCompounds_21" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_AgreementTerminationPeriod" xlink:label="loc_mrna_AgreementTerminationPeriod"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_IntellectualPropertyAndCollaborativeAgreementsLineItems_14" xlink:to="loc_mrna_AgreementTerminationPeriod" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_FutureAdditionalSelectionUpfrontPayment" xlink:label="loc_mrna_FutureAdditionalSelectionUpfrontPayment"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_IntellectualPropertyAndCollaborativeAgreementsLineItems_14" xlink:to="loc_mrna_FutureAdditionalSelectionUpfrontPayment" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | </presentationLink> |
| <presentationLink xlink:type="extended" xlink:role="http://www.marinabiotech.com/role/IntellectualPropertyAndCollaborativeAgreementsDetailTextuals1"> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_IntellectualPropertyAndContractualAgreementsAbstract" xlink:label="loc_mrna_IntellectualPropertyAndContractualAgreementsAbstract_0"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_IntellectualPropertyAndCollaborativeAgreementsTable" xlink:label="loc_mrna_IntellectualPropertyAndCollaborativeAgreementsTable_1"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_IntellectualPropertyAndContractualAgreementsAbstract_0" xlink:to="loc_mrna_IntellectualPropertyAndCollaborativeAgreementsTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_2"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_IntellectualPropertyAndCollaborativeAgreementsTable_1" xlink:to="loc_dei_LegalEntityAxis_2" order="0" use="optional"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_3"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_2" xlink:to="loc_dei_EntityDomain_3" order="0" use="optional"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_DebiopharmMember" xlink:label="loc_mrna_DebiopharmMember_4"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_3" xlink:to="loc_mrna_DebiopharmMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_ValeantPharmaceuticalsMember" xlink:label="loc_mrna_ValeantPharmaceuticalsMember_5"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_3" xlink:to="loc_mrna_ValeantPharmaceuticalsMember_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_NovosomAgMember" xlink:label="loc_mrna_NovosomAgMember_6"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_3" xlink:to="loc_mrna_NovosomAgMember_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_FHoffmannLaRocheIncAndFHoffmannLaRocheLtdMember" xlink:label="loc_mrna_FHoffmannLaRocheIncAndFHoffmannLaRocheLtdMember_7"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_3" xlink:to="loc_mrna_FHoffmannLaRocheIncAndFHoffmannLaRocheLtdMember_7" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_UniversityOfHelsinkiMember" xlink:label="loc_mrna_UniversityOfHelsinkiMember_9"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_3" xlink:to="loc_mrna_UniversityOfHelsinkiMember_9" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_RibotaskAspMember" xlink:label="loc_mrna_RibotaskAspMember_10"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_3" xlink:to="loc_mrna_RibotaskAspMember_10" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_TypeOfConformationallyRestrictedNucleotideProductAxis" xlink:label="loc_mrna_TypeOfConformationallyRestrictedNucleotideProductAxis_11"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_IntellectualPropertyAndCollaborativeAgreementsTable_1" xlink:to="loc_mrna_TypeOfConformationallyRestrictedNucleotideProductAxis_11" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_TypeOfConformationallyRestrictedNucleotideProductDomain" xlink:label="loc_mrna_TypeOfConformationallyRestrictedNucleotideProductDomain_12"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_TypeOfConformationallyRestrictedNucleotideProductAxis_11" xlink:to="loc_mrna_TypeOfConformationallyRestrictedNucleotideProductDomain_12" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_FirstConformationallyRestrictedNucleotideProductMember" xlink:label="loc_mrna_FirstConformationallyRestrictedNucleotideProductMember_13"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_TypeOfConformationallyRestrictedNucleotideProductDomain_12" xlink:to="loc_mrna_FirstConformationallyRestrictedNucleotideProductMember_13" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_SecondConformationallyRestrictedNucleotideProductMember" xlink:label="loc_mrna_SecondConformationallyRestrictedNucleotideProductMember_14"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_TypeOfConformationallyRestrictedNucleotideProductDomain_12" xlink:to="loc_mrna_SecondConformationallyRestrictedNucleotideProductMember_14" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_15"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_IntellectualPropertyAndCollaborativeAgreementsTable_1" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_15" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_16"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_15" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_16" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_17"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_16" xlink:to="loc_us-gaap_SubsequentEventMember_17" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_IntellectualPropertyAndCollaborativeAgreementsLineItems" xlink:label="loc_mrna_IntellectualPropertyAndCollaborativeAgreementsLineItems_18"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_IntellectualPropertyAndCollaborativeAgreementsTable_1" xlink:to="loc_mrna_IntellectualPropertyAndCollaborativeAgreementsLineItems_18" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredRevenueRevenueRecognized" xlink:label="loc_us-gaap_DeferredRevenueRevenueRecognized_19"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_IntellectualPropertyAndCollaborativeAgreementsLineItems_18" xlink:to="loc_us-gaap_DeferredRevenueRevenueRecognized_19" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_DevelopmentMilestonePayments" xlink:label="loc_mrna_DevelopmentMilestonePayments_20"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_IntellectualPropertyAndCollaborativeAgreementsLineItems_18" xlink:to="loc_mrna_DevelopmentMilestonePayments_20" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_LiabilityRelatedToSubLicenseRevenue" xlink:label="loc_mrna_LiabilityRelatedToSubLicenseRevenue_21"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_IntellectualPropertyAndCollaborativeAgreementsLineItems_18" xlink:to="loc_mrna_LiabilityRelatedToSubLicenseRevenue_21" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_ThresholdLimitOfEanedOutPayments" xlink:label="loc_mrna_ThresholdLimitOfEanedOutPayments_22"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_IntellectualPropertyAndCollaborativeAgreementsLineItems_18" xlink:to="loc_mrna_ThresholdLimitOfEanedOutPayments_22" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_AnnualPaymentForPerAssignedPatents" xlink:label="loc_mrna_AnnualPaymentForPerAssignedPatents_23"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_IntellectualPropertyAndCollaborativeAgreementsLineItems_18" xlink:to="loc_mrna_AnnualPaymentForPerAssignedPatents_23" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets_24"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_IntellectualPropertyAndCollaborativeAgreementsLineItems_18" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets_24" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets_25"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_IntellectualPropertyAndCollaborativeAgreementsLineItems_18" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets_25" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_ContractualAgreementsAssetsAcquiredPaymentPercentage" xlink:label="loc_mrna_ContractualAgreementsAssetsAcquiredPaymentPercentage_26"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_IntellectualPropertyAndCollaborativeAgreementsLineItems_18" xlink:to="loc_mrna_ContractualAgreementsAssetsAcquiredPaymentPercentage_26" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_AssetsAcquiredAdditionalConsiderationMaximum" xlink:label="loc_mrna_AssetsAcquiredAdditionalConsiderationMaximum_27"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_IntellectualPropertyAndCollaborativeAgreementsLineItems_18" xlink:to="loc_mrna_AssetsAcquiredAdditionalConsiderationMaximum_27" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_28"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_IntellectualPropertyAndCollaborativeAgreementsLineItems_18" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_28" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_CommonStockReservedForFutureIssuanceAsAdditionalConsideration" xlink:label="loc_mrna_CommonStockReservedForFutureIssuanceAsAdditionalConsideration_29"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_IntellectualPropertyAndCollaborativeAgreementsLineItems_18" xlink:to="loc_mrna_CommonStockReservedForFutureIssuanceAsAdditionalConsideration_29" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_CashPayable" xlink:label="loc_mrna_CashPayable_30"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_IntellectualPropertyAndCollaborativeAgreementsLineItems_18" xlink:to="loc_mrna_CashPayable_30" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_AdditionalCommonStockReservedForFutureIssuanceAsConsideration" xlink:label="loc_mrna_AdditionalCommonStockReservedForFutureIssuanceAsConsideration_31"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_IntellectualPropertyAndCollaborativeAgreementsLineItems_18" xlink:to="loc_mrna_AdditionalCommonStockReservedForFutureIssuanceAsConsideration_31" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_LicenseFeePayable" xlink:label="loc_mrna_LicenseFeePayable_32"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_IntellectualPropertyAndCollaborativeAgreementsLineItems_18" xlink:to="loc_mrna_LicenseFeePayable_32" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_LicenseFeePaid" xlink:label="loc_mrna_LicenseFeePaid_33"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_IntellectualPropertyAndCollaborativeAgreementsLineItems_18" xlink:to="loc_mrna_LicenseFeePaid_33" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_RoyaltyAdvance" xlink:label="loc_mrna_RoyaltyAdvance_35"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_IntellectualPropertyAndCollaborativeAgreementsLineItems_18" xlink:to="loc_mrna_RoyaltyAdvance_35" order="160" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_IntellectualPropertyPayments" xlink:label="loc_mrna_IntellectualPropertyPayments_36"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_IntellectualPropertyAndCollaborativeAgreementsLineItems_18" xlink:to="loc_mrna_IntellectualPropertyPayments_36" order="170" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_RemainingPaymentUnderAgreement" xlink:label="loc_mrna_RemainingPaymentUnderAgreement_37"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_IntellectualPropertyAndCollaborativeAgreementsLineItems_18" xlink:to="loc_mrna_RemainingPaymentUnderAgreement_37" order="180" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | </presentationLink> |
| <presentationLink xlink:type="extended" xlink:role="http://www.marinabiotech.com/role/BusinessLiquidityAndSummaryOfSignificantAccountingPoliciesDetails"> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_2"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_3"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_2" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_4"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_3" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_7"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_8"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_9"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_10"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_10" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_FairValueLiabilityForPriceAdjustableWarrants" xlink:label="loc_mrna_FairValueLiabilityForPriceAdjustableWarrants_11"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" xlink:to="loc_mrna_FairValueLiabilityForPriceAdjustableWarrants_11" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_FairValueLiabilityForPriceAdjustableSubscriptionInvestmentUnits" xlink:label="loc_mrna_FairValueLiabilityForPriceAdjustableSubscriptionInvestmentUnits_12"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" xlink:to="loc_mrna_FairValueLiabilityForPriceAdjustableSubscriptionInvestmentUnits_12" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_FairValueOfStockToBeIssuedToSettleLiabilities" xlink:label="loc_mrna_FairValueOfStockToBeIssuedToSettleLiabilities_13"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" xlink:to="loc_mrna_FairValueOfStockToBeIssuedToSettleLiabilities_13" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_14"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_14" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_10" xlink:to="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | </presentationLink> |
| <presentationLink xlink:type="extended" xlink:role="http://www.marinabiotech.com/role/BusinessLiquidityAndSummaryOfSignificantAccountingPoliciesDetails1"> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_1"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_2"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_1" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_3"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_2" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_AccruedRestructuringLiabilityMember" xlink:label="loc_mrna_AccruedRestructuringLiabilityMember_4"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_3" xlink:to="loc_mrna_AccruedRestructuringLiabilityMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_1" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_7"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_8"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_1" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_8" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_9"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_8" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_10"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_9" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_10" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityAccruals" xlink:label="loc_mrna_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityAccruals_11"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_9" xlink:to="loc_mrna_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityAccruals_11" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_12"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_9" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_12" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityAccretion" xlink:label="loc_mrna_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityAccretion_13"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_9" xlink:to="loc_mrna_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityAccretion_13" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_9" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_FairValueMeasurementWithUnobservableInputsCommonStockIssuedToTerminateLease" xlink:label="loc_mrna_FairValueMeasurementWithUnobservableInputsCommonStockIssuedToTerminateLease"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_9" xlink:to="loc_mrna_FairValueMeasurementWithUnobservableInputsCommonStockIssuedToTerminateLease" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | </presentationLink> |
| <presentationLink xlink:type="extended" xlink:role="http://www.marinabiotech.com/role/BusinessLiquidityAndSummaryOfSignificantAccountingPoliciesDetails2"> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_1"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_2"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_1" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_3"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_2" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_FairValueLiabilityForPriceAdjustableWarrantsMember" xlink:label="loc_mrna_FairValueLiabilityForPriceAdjustableWarrantsMember_4"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_3" xlink:to="loc_mrna_FairValueLiabilityForPriceAdjustableWarrantsMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_1" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_7"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_WarrantsIssuedInAmendmentAxis" xlink:label="loc_mrna_WarrantsIssuedInAmendmentAxis_8"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_1" xlink:to="loc_mrna_WarrantsIssuedInAmendmentAxis_8" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_WarrantsIssuedInAmendmentDomain" xlink:label="loc_mrna_WarrantsIssuedInAmendmentDomain_9"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_WarrantsIssuedInAmendmentAxis_8" xlink:to="loc_mrna_WarrantsIssuedInAmendmentDomain_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_AmendmentOneMember" xlink:label="loc_mrna_AmendmentOneMember_10"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_WarrantsIssuedInAmendmentDomain_9" xlink:to="loc_mrna_AmendmentOneMember_10" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_AmendmentTwoMember" xlink:label="loc_mrna_AmendmentTwoMember_11"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_WarrantsIssuedInAmendmentDomain_9" xlink:to="loc_mrna_AmendmentTwoMember_11" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_AmendmentThreeMember" xlink:label="loc_mrna_AmendmentThreeMember_12"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_WarrantsIssuedInAmendmentDomain_9" xlink:to="loc_mrna_AmendmentThreeMember_12" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_AmendmentFourMember" xlink:label="loc_mrna_AmendmentFourMember_13"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_WarrantsIssuedInAmendmentDomain_9" xlink:to="loc_mrna_AmendmentFourMember_13" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_14"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_1" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_14" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_15"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_14" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_15" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_16"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_15" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_16" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_ReclassificationOfFairValueLiabilityForPriceAdjustableWarrantsExercised" xlink:label="loc_mrna_ReclassificationOfFairValueLiabilityForPriceAdjustableWarrantsExercised_17"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_15" xlink:to="loc_mrna_ReclassificationOfFairValueLiabilityForPriceAdjustableWarrantsExercised_17" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_FairValueOfWarrantsIssued" xlink:label="loc_mrna_FairValueOfWarrantsIssued_18"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_15" xlink:to="loc_mrna_FairValueOfWarrantsIssued_18" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_ChangeInFairValueLiabilityForPriceAdjustableWarrantsAndSubscriptionInvestmentUnits" xlink:label="loc_mrna_ChangeInFairValueLiabilityForPriceAdjustableWarrantsAndSubscriptionInvestmentUnits_19"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_15" xlink:to="loc_mrna_ChangeInFairValueLiabilityForPriceAdjustableWarrantsAndSubscriptionInvestmentUnits_19" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_FairValueOfWarrantsExercised" xlink:label="loc_mrna_FairValueOfWarrantsExercised_20"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_15" xlink:to="loc_mrna_FairValueOfWarrantsExercised_20" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_21"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_15" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_21" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_ExercisePriceRollForward" xlink:label="loc_mrna_ExercisePriceRollForward_22"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_14" xlink:to="loc_mrna_ExercisePriceRollForward_22" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueAssumptionsExercisePrice" xlink:label="loc_us-gaap_FairValueAssumptionsExercisePrice_23"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_ExercisePriceRollForward_22" xlink:to="loc_us-gaap_FairValueAssumptionsExercisePrice_23" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_ReclassificationOfFairValueLiabilityForPriceAdjustableWarrantsExercisedExercisePrice" xlink:label="loc_mrna_ReclassificationOfFairValueLiabilityForPriceAdjustableWarrantsExercisedExercisePrice_24"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_ExercisePriceRollForward_22" xlink:to="loc_mrna_ReclassificationOfFairValueLiabilityForPriceAdjustableWarrantsExercisedExercisePrice_24" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_FairValueOfWarrantsIssuedExercisePrice" xlink:label="loc_mrna_FairValueOfWarrantsIssuedExercisePrice_25"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_ExercisePriceRollForward_22" xlink:to="loc_mrna_FairValueOfWarrantsIssuedExercisePrice_25" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_FairValueOfPerWarrantExercised" xlink:label="loc_mrna_FairValueOfPerWarrantExercised_26"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_ExercisePriceRollForward_22" xlink:to="loc_mrna_FairValueOfPerWarrantExercised_26" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueAssumptionsExercisePrice" xlink:label="loc_us-gaap_FairValueAssumptionsExercisePrice_27"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_ExercisePriceRollForward_22" xlink:to="loc_us-gaap_FairValueAssumptionsExercisePrice_27" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_StockPriceRollForward" xlink:label="loc_mrna_StockPriceRollForward_28"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_14" xlink:to="loc_mrna_StockPriceRollForward_28" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_29"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockPriceRollForward_28" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_29" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_ReclassificationOfFairValueLiabilityForPriceAdjustableWarrantsExercisedStockPrice" xlink:label="loc_mrna_ReclassificationOfFairValueLiabilityForPriceAdjustableWarrantsExercisedStockPrice_30"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockPriceRollForward_28" xlink:to="loc_mrna_ReclassificationOfFairValueLiabilityForPriceAdjustableWarrantsExercisedStockPrice_30" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_FairValueOfWarrantsIssuedStockPrice" xlink:label="loc_mrna_FairValueOfWarrantsIssuedStockPrice_31"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockPriceRollForward_28" xlink:to="loc_mrna_FairValueOfWarrantsIssuedStockPrice_31" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_FairValueOfWarrantsExercisedStockPrice" xlink:label="loc_mrna_FairValueOfWarrantsExercisedStockPrice_32"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockPriceRollForward_28" xlink:to="loc_mrna_FairValueOfWarrantsExercisedStockPrice_32" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_33"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockPriceRollForward_28" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_33" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_VolatilityRollForward" xlink:label="loc_mrna_VolatilityRollForward_34"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_14" xlink:to="loc_mrna_VolatilityRollForward_34" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_FairValueAssumptionsVolatility" xlink:label="loc_mrna_FairValueAssumptionsVolatility_35"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_VolatilityRollForward_34" xlink:to="loc_mrna_FairValueAssumptionsVolatility_35" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_ReclassificationOfFairValueLiabilityForPriceAdjustableWarrantsExercisedVolatility" xlink:label="loc_mrna_ReclassificationOfFairValueLiabilityForPriceAdjustableWarrantsExercisedVolatility_36"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_VolatilityRollForward_34" xlink:to="loc_mrna_ReclassificationOfFairValueLiabilityForPriceAdjustableWarrantsExercisedVolatility_36" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_FairValueOfWarrantsIssuedVolatility" xlink:label="loc_mrna_FairValueOfWarrantsIssuedVolatility_37"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_VolatilityRollForward_34" xlink:to="loc_mrna_FairValueOfWarrantsIssuedVolatility_37" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_FairValueOfWarrantsExercisedVolatility" xlink:label="loc_mrna_FairValueOfWarrantsExercisedVolatility_38"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_VolatilityRollForward_34" xlink:to="loc_mrna_FairValueOfWarrantsExercisedVolatility_38" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_FairValueAssumptionsVolatility" xlink:label="loc_mrna_FairValueAssumptionsVolatility_39"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_VolatilityRollForward_34" xlink:to="loc_mrna_FairValueAssumptionsVolatility_39" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_ContractualLifeInYearsRollForward" xlink:label="loc_mrna_ContractualLifeInYearsRollForward_40"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_14" xlink:to="loc_mrna_ContractualLifeInYearsRollForward_40" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_FairValueAssumptionsTerm" xlink:label="loc_mrna_FairValueAssumptionsTerm_41"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_ContractualLifeInYearsRollForward_40" xlink:to="loc_mrna_FairValueAssumptionsTerm_41" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_ReclassificationOfFairValueLiabilityForPriceAdjustableWarrantsExercisedTerm" xlink:label="loc_mrna_ReclassificationOfFairValueLiabilityForPriceAdjustableWarrantsExercisedTerm_42"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_ContractualLifeInYearsRollForward_40" xlink:to="loc_mrna_ReclassificationOfFairValueLiabilityForPriceAdjustableWarrantsExercisedTerm_42" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_FairValueOfWarrantsIssuedTerm" xlink:label="loc_mrna_FairValueOfWarrantsIssuedTerm_43"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_ContractualLifeInYearsRollForward_40" xlink:to="loc_mrna_FairValueOfWarrantsIssuedTerm_43" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_FairValueOfWarrantExercisedTerm" xlink:label="loc_mrna_FairValueOfWarrantExercisedTerm_44"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_ContractualLifeInYearsRollForward_40" xlink:to="loc_mrna_FairValueOfWarrantExercisedTerm_44" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_RiskFreeRollForward" xlink:label="loc_mrna_RiskFreeRollForward_46"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_14" xlink:to="loc_mrna_RiskFreeRollForward_46" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_FairValueAssumptionsRiskFreeRate" xlink:label="loc_mrna_FairValueAssumptionsRiskFreeRate_47"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_RiskFreeRollForward_46" xlink:to="loc_mrna_FairValueAssumptionsRiskFreeRate_47" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_ReclassificationOfFairValueLiabilityForPriceAdjustableWarrantsExercisedRiskFreeRate" xlink:label="loc_mrna_ReclassificationOfFairValueLiabilityForPriceAdjustableWarrantsExercisedRiskFreeRate_48"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_RiskFreeRollForward_46" xlink:to="loc_mrna_ReclassificationOfFairValueLiabilityForPriceAdjustableWarrantsExercisedRiskFreeRate_48" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_FairValueOfWarrantsIssuedRiskFreeRate" xlink:label="loc_mrna_FairValueOfWarrantsIssuedRiskFreeRate_49"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_RiskFreeRollForward_46" xlink:to="loc_mrna_FairValueOfWarrantsIssuedRiskFreeRate_49" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_FairValueOfWarrantsExercisedRiskFree" xlink:label="loc_mrna_FairValueOfWarrantsExercisedRiskFree_50"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_RiskFreeRollForward_46" xlink:to="loc_mrna_FairValueOfWarrantsExercisedRiskFree_50" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_FairValueAssumptionsRiskFreeRate" xlink:label="loc_mrna_FairValueAssumptionsRiskFreeRate_51"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_RiskFreeRollForward_46" xlink:to="loc_mrna_FairValueAssumptionsRiskFreeRate_51" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/> |
| | </presentationLink> |
| <presentationLink xlink:type="extended" xlink:role="http://www.marinabiotech.com/role/BusinessLiquidityAndSummaryOfSignificantAccountingPoliciesDetails3"> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_1"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_2"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_1" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_3"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_2" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_FairValueLiabilityForPriceAdjustableSubscriptionInvestmentUnitMember" xlink:label="loc_mrna_FairValueLiabilityForPriceAdjustableSubscriptionInvestmentUnitMember_4"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_3" xlink:to="loc_mrna_FairValueLiabilityForPriceAdjustableSubscriptionInvestmentUnitMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_1" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_7"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_8"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_1" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_8" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_9"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_8" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_10"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_9" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_10" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_ReclassificationOfFairValueLiabilityForPriceAdjustableWarrantsExercised" xlink:label="loc_mrna_ReclassificationOfFairValueLiabilityForPriceAdjustableWarrantsExercised_11"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_9" xlink:to="loc_mrna_ReclassificationOfFairValueLiabilityForPriceAdjustableWarrantsExercised_11" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_ChangeInFairValueLiabilityForPriceAdjustableWarrantsAndSubscriptionInvestmentUnits" xlink:label="loc_mrna_ChangeInFairValueLiabilityForPriceAdjustableWarrantsAndSubscriptionInvestmentUnits_12"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_9" xlink:to="loc_mrna_ChangeInFairValueLiabilityForPriceAdjustableWarrantsAndSubscriptionInvestmentUnits_12" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_ExpirationOfUnexercisedUnits" xlink:label="loc_mrna_ExpirationOfUnexercisedUnits_13"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_9" xlink:to="loc_mrna_ExpirationOfUnexercisedUnits_13" order="30" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_14"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_9" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_14" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_ExercisePriceRollForward" xlink:label="loc_mrna_ExercisePriceRollForward_15"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_8" xlink:to="loc_mrna_ExercisePriceRollForward_15" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueAssumptionsExercisePrice" xlink:label="loc_us-gaap_FairValueAssumptionsExercisePrice_16"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_ExercisePriceRollForward_15" xlink:to="loc_us-gaap_FairValueAssumptionsExercisePrice_16" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_ReclassificationOfFairValueLiabilityForPriceAdjustableWarrantsExercisedExercisePrice" xlink:label="loc_mrna_ReclassificationOfFairValueLiabilityForPriceAdjustableWarrantsExercisedExercisePrice_17"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_ExercisePriceRollForward_15" xlink:to="loc_mrna_ReclassificationOfFairValueLiabilityForPriceAdjustableWarrantsExercisedExercisePrice_17" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueAssumptionsExercisePrice" xlink:label="loc_us-gaap_FairValueAssumptionsExercisePrice_18"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_ExercisePriceRollForward_15" xlink:to="loc_us-gaap_FairValueAssumptionsExercisePrice_18" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_StockPriceRollForward" xlink:label="loc_mrna_StockPriceRollForward_19"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_8" xlink:to="loc_mrna_StockPriceRollForward_19" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_20"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockPriceRollForward_19" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_20" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_ReclassificationOfFairValueLiabilityForPriceAdjustableWarrantsExercisedStockPrice" xlink:label="loc_mrna_ReclassificationOfFairValueLiabilityForPriceAdjustableWarrantsExercisedStockPrice_21"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockPriceRollForward_19" xlink:to="loc_mrna_ReclassificationOfFairValueLiabilityForPriceAdjustableWarrantsExercisedStockPrice_21" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_22"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockPriceRollForward_19" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_22" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_VolatilityRollForward" xlink:label="loc_mrna_VolatilityRollForward_23"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_8" xlink:to="loc_mrna_VolatilityRollForward_23" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_FairValueAssumptionsVolatility" xlink:label="loc_mrna_FairValueAssumptionsVolatility_24"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_VolatilityRollForward_23" xlink:to="loc_mrna_FairValueAssumptionsVolatility_24" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_ReclassificationOfFairValueLiabilityForPriceAdjustableWarrantsExercisedVolatility" xlink:label="loc_mrna_ReclassificationOfFairValueLiabilityForPriceAdjustableWarrantsExercisedVolatility_25"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_VolatilityRollForward_23" xlink:to="loc_mrna_ReclassificationOfFairValueLiabilityForPriceAdjustableWarrantsExercisedVolatility_25" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_FairValueAssumptionsVolatility" xlink:label="loc_mrna_FairValueAssumptionsVolatility_26"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_VolatilityRollForward_23" xlink:to="loc_mrna_FairValueAssumptionsVolatility_26" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_ContractualLifeInYearsRollForward" xlink:label="loc_mrna_ContractualLifeInYearsRollForward_27"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_8" xlink:to="loc_mrna_ContractualLifeInYearsRollForward_27" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_FairValueAssumptionsTerm" xlink:label="loc_mrna_FairValueAssumptionsTerm_28"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_ContractualLifeInYearsRollForward_27" xlink:to="loc_mrna_FairValueAssumptionsTerm_28" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_ReclassificationOfFairValueLiabilityForPriceAdjustableWarrantsExercisedTerm" xlink:label="loc_mrna_ReclassificationOfFairValueLiabilityForPriceAdjustableWarrantsExercisedTerm_29"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_ContractualLifeInYearsRollForward_27" xlink:to="loc_mrna_ReclassificationOfFairValueLiabilityForPriceAdjustableWarrantsExercisedTerm_29" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_RiskFreeRollForward" xlink:label="loc_mrna_RiskFreeRollForward_31"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_8" xlink:to="loc_mrna_RiskFreeRollForward_31" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_FairValueAssumptionsRiskFreeRate" xlink:label="loc_mrna_FairValueAssumptionsRiskFreeRate_32"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_RiskFreeRollForward_31" xlink:to="loc_mrna_FairValueAssumptionsRiskFreeRate_32" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_ReclassificationOfFairValueLiabilityForPriceAdjustableWarrantsExercisedRiskFreeRate" xlink:label="loc_mrna_ReclassificationOfFairValueLiabilityForPriceAdjustableWarrantsExercisedRiskFreeRate_33"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_RiskFreeRollForward_31" xlink:to="loc_mrna_ReclassificationOfFairValueLiabilityForPriceAdjustableWarrantsExercisedRiskFreeRate_33" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_FairValueAssumptionsRiskFreeRate" xlink:label="loc_mrna_FairValueAssumptionsRiskFreeRate_34"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_RiskFreeRollForward_31" xlink:to="loc_mrna_FairValueAssumptionsRiskFreeRate_34" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/> |
| | </presentationLink> |
| <presentationLink xlink:type="extended" xlink:role="http://www.marinabiotech.com/role/BusinessLiquidityAndSummaryOfSignificantAccountingPoliciesDetails4"> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConcentrationRiskTable" xlink:label="loc_us-gaap_ConcentrationRiskTable_1"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0" xlink:to="loc_us-gaap_ConcentrationRiskTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_2"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_1" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_3"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_2" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SalesRevenueGoodsNetMember" xlink:label="loc_us-gaap_SalesRevenueGoodsNetMember_4"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_3" xlink:to="loc_us-gaap_SalesRevenueGoodsNetMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_MajorCustomerAxis" xlink:label="loc_mrna_MajorCustomerAxis_5"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_1" xlink:to="loc_mrna_MajorCustomerAxis_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_MajorCustomerDomain" xlink:label="loc_mrna_MajorCustomerDomain_6"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_MajorCustomerAxis_5" xlink:to="loc_mrna_MajorCustomerDomain_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_MonsantoMember" xlink:label="loc_mrna_MonsantoMember_7"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_MajorCustomerDomain_6" xlink:to="loc_mrna_MonsantoMember_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_NovartisMember" xlink:label="loc_mrna_NovartisMember_8"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_MajorCustomerDomain_6" xlink:to="loc_mrna_NovartisMember_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_DebiopharmMember" xlink:label="loc_mrna_DebiopharmMember_9"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_MajorCustomerDomain_6" xlink:to="loc_mrna_DebiopharmMember_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_TekmiraMember" xlink:label="loc_mrna_TekmiraMember_10"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_MajorCustomerDomain_6" xlink:to="loc_mrna_TekmiraMember_10" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_PronaiTherapeuticsIncMember" xlink:label="loc_mrna_PronaiTherapeuticsIncMember_11"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_MajorCustomerDomain_6" xlink:to="loc_mrna_PronaiTherapeuticsIncMember_11" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_MirnaTherapeuticsMember" xlink:label="loc_mrna_MirnaTherapeuticsMember_12"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_MajorCustomerDomain_6" xlink:to="loc_mrna_MirnaTherapeuticsMember_12" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_OtherCustomersMember" xlink:label="loc_mrna_OtherCustomersMember_13"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_MajorCustomerDomain_6" xlink:to="loc_mrna_OtherCustomersMember_13" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_RocheMember" xlink:label="loc_mrna_RocheMember_14"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_MajorCustomerDomain_6" xlink:to="loc_mrna_RocheMember_14" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_15"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_1" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_15" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_16"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_15" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_16" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | </presentationLink> |
| <presentationLink xlink:type="extended" xlink:role="http://www.marinabiotech.com/role/BusinessLiquidityAndSummaryOfSignificantAccountingPoliciesDetails5"> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_2"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_2" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_4"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3" xlink:to="loc_us-gaap_EmployeeStockOptionMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember_5"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3" xlink:to="loc_us-gaap_WarrantMember_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubscriptionArrangementMember" xlink:label="loc_us-gaap_SubscriptionArrangementMember_6"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3" xlink:to="loc_us-gaap_SubscriptionArrangementMember_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_SharesIssuableOnOptionalDebtConversionMember" xlink:label="loc_mrna_SharesIssuableOnOptionalDebtConversionMember_7"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3" xlink:to="loc_mrna_SharesIssuableOnOptionalDebtConversionMember_7" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_8"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_9"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_8" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | </presentationLink> |
| <presentationLink xlink:type="extended" xlink:role="http://www.marinabiotech.com/role/BusinessLiquidityAndSummaryOfSignificantAccountingPoliciesDetailTextuals"> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_BusinessGoingConcernAndSummaryOfSignificantAccountingPoliciesTable" xlink:label="loc_mrna_BusinessGoingConcernAndSummaryOfSignificantAccountingPoliciesTable_1"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0" xlink:to="loc_mrna_BusinessGoingConcernAndSummaryOfSignificantAccountingPoliciesTable_1" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_5"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_BusinessGoingConcernAndSummaryOfSignificantAccountingPoliciesTable_1" xlink:to="loc_us-gaap_StatementClassOfStockAxis_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_6"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_5" xlink:to="loc_us-gaap_ClassOfStockDomain_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="loc_us-gaap_SeriesCPreferredStockMember_7"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_6" xlink:to="loc_us-gaap_SeriesCPreferredStockMember_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_BusinessGoingConcernAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:label="loc_mrna_BusinessGoingConcernAndSummaryOfSignificantAccountingPoliciesLineItems_8"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_BusinessGoingConcernAndSummaryOfSignificantAccountingPoliciesTable_1" xlink:to="loc_mrna_BusinessGoingConcernAndSummaryOfSignificantAccountingPoliciesLineItems_8" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_9"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_9" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_WorkingCapitalSurplusDeficit" xlink:label="loc_mrna_WorkingCapitalSurplusDeficit_10"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0" xlink:to="loc_mrna_WorkingCapitalSurplusDeficit_10" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_13"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_BusinessGoingConcernAndSummaryOfSignificantAccountingPoliciesLineItems_8" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_13" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_14"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_BusinessGoingConcernAndSummaryOfSignificantAccountingPoliciesLineItems_8" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_14" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_15"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_BusinessGoingConcernAndSummaryOfSignificantAccountingPoliciesLineItems_8" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_15" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_16"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_BusinessGoingConcernAndSummaryOfSignificantAccountingPoliciesLineItems_8" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_16" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights_17"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_BusinessGoingConcernAndSummaryOfSignificantAccountingPoliciesLineItems_8" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights_17" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_18"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_BusinessGoingConcernAndSummaryOfSignificantAccountingPoliciesLineItems_8" xlink:to="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_18" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_FinancingConsumedToRunMinimizedBusinessOperations" xlink:label="loc_mrna_FinancingConsumedToRunMinimizedBusinessOperations"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_BusinessGoingConcernAndSummaryOfSignificantAccountingPoliciesLineItems_8" xlink:to="loc_mrna_FinancingConsumedToRunMinimizedBusinessOperations" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_BusinessGoingConcernAndSummaryOfSignificantAccountingPoliciesTable_1" xlink:to="loc_us-gaap_SubsequentEventTypeAxis" order="20" use="optional"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="loc_us-gaap_SubsequentEventTypeDomain" order="0" use="optional"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="loc_us-gaap_SubsequentEventMember" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_BusinessGoingConcernAndSummaryOfSignificantAccountingPoliciesLineItems_8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDepreciationMethods" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDepreciationMethods"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_BusinessGoingConcernAndSummaryOfSignificantAccountingPoliciesLineItems_8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDepreciationMethods" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_BusinessGoingConcernAndSummaryOfSignificantAccountingPoliciesTable_1" xlink:to="loc_us-gaap_RangeAxis" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeAxis" xlink:to="loc_us-gaap_RangeMember" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaap_MinimumMember"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember" xlink:to="loc_us-gaap_MinimumMember" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember" xlink:to="loc_us-gaap_MaximumMember" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_BusinessGoingConcernAndSummaryOfSignificantAccountingPoliciesLineItems_8" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | </presentationLink> |
| <presentationLink xlink:type="extended" xlink:role="http://www.marinabiotech.com/role/LossOnImpairmentOfIntangibleAssetsDetailTextuals"> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_0"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_0" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_2"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_2" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_CequentPharmaceuticalsIncMember" xlink:label="loc_mrna_CequentPharmaceuticalsIncMember_4"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3" xlink:to="loc_mrna_CequentPharmaceuticalsIncMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_5"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_6"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_5" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_FamilialAdenomatousPolyposisMember" xlink:label="loc_mrna_FamilialAdenomatousPolyposisMember_7"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_6" xlink:to="loc_mrna_FamilialAdenomatousPolyposisMember_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_TranskingdomRnaInterferenceMember" xlink:label="loc_mrna_TranskingdomRnaInterferenceMember_8"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_6" xlink:to="loc_mrna_TranskingdomRnaInterferenceMember_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_9"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_10"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_10" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueInputsDiscountRate" xlink:label="loc_us-gaap_FairValueInputsDiscountRate_11"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9" xlink:to="loc_us-gaap_FairValueInputsDiscountRate_11" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_12"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_12" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | </presentationLink> |
| <presentationLink xlink:type="extended" xlink:role="http://www.marinabiotech.com/role/LossOnImpairmentOfIntangibleAssetsDetailTextuals1"> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_0"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_0" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_2"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_2" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_CequentPharmaceuticalsIncMember" xlink:label="loc_mrna_CequentPharmaceuticalsIncMember_4"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3" xlink:to="loc_mrna_CequentPharmaceuticalsIncMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_5"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_6"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsOtherTaxCarryforwards" xlink:label="loc_us-gaap_DeferredTaxAssetsOtherTaxCarryforwards_7"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5" xlink:to="loc_us-gaap_DeferredTaxAssetsOtherTaxCarryforwards_7" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_8"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_8" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_9"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_9" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_DeferredTaxAssetsRelatedToAcquiredAssets" xlink:label="loc_mrna_DeferredTaxAssetsRelatedToAcquiredAssets_10"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5" xlink:to="loc_mrna_DeferredTaxAssetsRelatedToAcquiredAssets_10" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAvailableToReduceIntangibleAssets" xlink:label="loc_us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAvailableToReduceIntangibleAssets_11"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5" xlink:to="loc_us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAvailableToReduceIntangibleAssets_11" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | </presentationLink> |
| <presentationLink xlink:type="extended" xlink:role="http://www.marinabiotech.com/role/PropertyandEquipmentDetails"> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_4"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_5"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_ComputerEquipmentAndSoftwareMember" xlink:label="loc_mrna_ComputerEquipmentAndSoftwareMember_6"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3" xlink:to="loc_mrna_ComputerEquipmentAndSoftwareMember_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_7"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_7" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_9"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_10"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_10" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_11"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_11" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/> |
| | </presentationLink> |
| <presentationLink xlink:type="extended" xlink:role="http://www.marinabiotech.com/role/PropertyAndEquipmentDetailTextuals"> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisposals" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisposals_1"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisposals_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | </presentationLink> |
| <presentationLink xlink:type="extended" xlink:role="http://www.marinabiotech.com/role/RestructuringChargesDetails"> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RestructuringChargesAbstract" xlink:label="loc_us-gaap_RestructuringChargesAbstract_0"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringChargesAbstract_0" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_2"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_3"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_2" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_PropertyAndEquipmentDisposalMember" xlink:label="loc_mrna_PropertyAndEquipmentDisposalMember_4"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_3" xlink:to="loc_mrna_PropertyAndEquipmentDisposalMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FacilityClosingMember" xlink:label="loc_us-gaap_FacilityClosingMember_5"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_3" xlink:to="loc_us-gaap_FacilityClosingMember_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmployeeSeveranceMember" xlink:label="loc_us-gaap_EmployeeSeveranceMember_6"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_3" xlink:to="loc_us-gaap_EmployeeSeveranceMember_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_7"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_7" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="loc_us-gaap_RestructuringCharges_8"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_7" xlink:to="loc_us-gaap_RestructuringCharges_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | </presentationLink> |
| <presentationLink xlink:type="extended" xlink:role="http://www.marinabiotech.com/role/RestructuringChargesDetailTextuals"> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RestructuringChargesAbstract" xlink:label="loc_us-gaap_RestructuringChargesAbstract_0"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringChargesAbstract_0" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_2"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_3"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_2" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FacilityClosingMember" xlink:label="loc_us-gaap_FacilityClosingMember_4"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_3" xlink:to="loc_us-gaap_FacilityClosingMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmployeeSeveranceMember" xlink:label="loc_us-gaap_EmployeeSeveranceMember_5"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_3" xlink:to="loc_us-gaap_EmployeeSeveranceMember_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_RestructuringByAreaAxis" xlink:label="loc_mrna_RestructuringByAreaAxis_6"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1" xlink:to="loc_mrna_RestructuringByAreaAxis_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_RestructuringByAreaDomain" xlink:label="loc_mrna_RestructuringByAreaDomain_7"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_RestructuringByAreaAxis_6" xlink:to="loc_mrna_RestructuringByAreaDomain_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_CambridgeOperationsMember" xlink:label="loc_mrna_CambridgeOperationsMember_8"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_RestructuringByAreaDomain_7" xlink:to="loc_mrna_CambridgeOperationsMember_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_WashingtonFacilityMember" xlink:label="loc_mrna_WashingtonFacilityMember_9"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_RestructuringByAreaDomain_7" xlink:to="loc_mrna_WashingtonFacilityMember_9" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_10"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_10" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaap_SharesIssued_11"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_10" xlink:to="loc_us-gaap_SharesIssued_11" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RestructuringReserveSettledWithoutCash1" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash1_12"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_10" xlink:to="loc_us-gaap_RestructuringReserveSettledWithoutCash1_12" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_RestructuringChargesAccretionRelatedToAccruedRestructuringLiabilityAndOtherFacilityRelatedCosts" xlink:label="loc_mrna_RestructuringChargesAccretionRelatedToAccruedRestructuringLiabilityAndOtherFacilityRelatedCosts_13"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_10" xlink:to="loc_mrna_RestructuringChargesAccretionRelatedToAccruedRestructuringLiabilityAndOtherFacilityRelatedCosts_13" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="loc_us-gaap_RestructuringCharges_14"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_10" xlink:to="loc_us-gaap_RestructuringCharges_14" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GainLossOnContractTermination" xlink:label="loc_us-gaap_GainLossOnContractTermination_15"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_10" xlink:to="loc_us-gaap_GainLossOnContractTermination_15" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost_16"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_10" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost_16" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCostRemaining" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining_17"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_10" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining_17" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_NumberOfSharesToBeIssuableOnCertainFutureFinancingEvents" xlink:label="loc_mrna_NumberOfSharesToBeIssuableOnCertainFutureFinancingEvents_18"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_10" xlink:to="loc_mrna_NumberOfSharesToBeIssuableOnCertainFutureFinancingEvents_18" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_ValueOfSharesToBeIssuableOnCertainFutureFinancingEvents" xlink:label="loc_mrna_ValueOfSharesToBeIssuableOnCertainFutureFinancingEvents_19"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_10" xlink:to="loc_mrna_ValueOfSharesToBeIssuableOnCertainFutureFinancingEvents_19" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EffectOnFutureEarningsAmount" xlink:label="loc_us-gaap_EffectOnFutureEarningsAmount_20"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_10" xlink:to="loc_us-gaap_EffectOnFutureEarningsAmount_20" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | </presentationLink> |
| <presentationLink xlink:type="extended" xlink:role="http://www.marinabiotech.com/role/NotesPayableDetailTextuals"> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongTermDebtOtherDisclosuresAbstract" xlink:label="loc_us-gaap_LongTermDebtOtherDisclosuresAbstract_0"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_1"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtOtherDisclosuresAbstract_0" xlink:to="loc_us-gaap_DebtInstrumentTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_2"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1" xlink:to="loc_us-gaap_DebtInstrumentAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_3"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_2" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_4"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_5"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_6"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_5" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PriceRiskDerivativeMember" xlink:label="loc_us-gaap_PriceRiskDerivativeMember_7"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6" xlink:to="loc_us-gaap_PriceRiskDerivativeMember_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_8"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1" xlink:to="loc_us-gaap_DebtInstrumentLineItems_8" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_9"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_10"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_10" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_DebtInstrumentNumberOfInvestors" xlink:label="loc_mrna_DebtInstrumentNumberOfInvestors_11"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8" xlink:to="loc_mrna_DebtInstrumentNumberOfInvestors_11" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_12"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_12" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights_13"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights_13" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | </presentationLink> |
| <presentationLink xlink:type="extended" xlink:role="http://www.marinabiotech.com/role/NotesPayableDetailTextuals1"> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongTermDebtOtherDisclosuresAbstract" xlink:label="loc_us-gaap_LongTermDebtOtherDisclosuresAbstract_0"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_1"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtOtherDisclosuresAbstract_0" xlink:to="loc_us-gaap_DebtInstrumentTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_2"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1" xlink:to="loc_us-gaap_DebtInstrumentAxis_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_3"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_2" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_4"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_5"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_5" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_6"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_5" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PriceRiskDerivativeMember" xlink:label="loc_us-gaap_PriceRiskDerivativeMember_7"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6" xlink:to="loc_us-gaap_PriceRiskDerivativeMember_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_DebtInstrumentAmendmentAxis" xlink:label="loc_mrna_DebtInstrumentAmendmentAxis_8"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1" xlink:to="loc_mrna_DebtInstrumentAmendmentAxis_8" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_DebtInstrumentAmendmentDomain" xlink:label="loc_mrna_DebtInstrumentAmendmentDomain_9"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_DebtInstrumentAmendmentAxis_8" xlink:to="loc_mrna_DebtInstrumentAmendmentDomain_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_DebtInstrumentAmendmentOneMember" xlink:label="loc_mrna_DebtInstrumentAmendmentOneMember_10"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_DebtInstrumentAmendmentDomain_9" xlink:to="loc_mrna_DebtInstrumentAmendmentOneMember_10" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_DebtInstrumentAmendmentTwoMember" xlink:label="loc_mrna_DebtInstrumentAmendmentTwoMember_11"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_DebtInstrumentAmendmentDomain_9" xlink:to="loc_mrna_DebtInstrumentAmendmentTwoMember_11" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_DebtInstrumentAmendmentThreeMember" xlink:label="loc_mrna_DebtInstrumentAmendmentThreeMember_12"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_DebtInstrumentAmendmentDomain_9" xlink:to="loc_mrna_DebtInstrumentAmendmentThreeMember_12" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_DebtInstrumentAmendmentFourMember" xlink:label="loc_mrna_DebtInstrumentAmendmentFourMember_13"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_DebtInstrumentAmendmentDomain_9" xlink:to="loc_mrna_DebtInstrumentAmendmentFourMember_13" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_14"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1" xlink:to="loc_us-gaap_DebtInstrumentLineItems_14" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_MandatoryPrepaymentOfAdditionalPriceAdjustableWarrants" xlink:label="loc_mrna_MandatoryPrepaymentOfAdditionalPriceAdjustableWarrants_15"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_14" xlink:to="loc_mrna_MandatoryPrepaymentOfAdditionalPriceAdjustableWarrants_15" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_16"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_14" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_16" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights_17"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_14" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights_17" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_MinimumEffectivePriceProtectionInEventOfCertainMergersOrAcquisitions" xlink:label="loc_mrna_MinimumEffectivePriceProtectionInEventOfCertainMergersOrAcquisitions_18"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_14" xlink:to="loc_mrna_MinimumEffectivePriceProtectionInEventOfCertainMergersOrAcquisitions_18" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentInterest" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentInterest"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_14" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentInterest" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_14" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet" xlink:label="loc_us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_14" xlink:to="loc_us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentAmount1"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_14" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentAmount1" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_14" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1" xlink:to="loc_us-gaap_SubsequentEventTypeAxis" order="40" use="optional"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="loc_us-gaap_SubsequentEventTypeDomain" order="0" use="optional"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="loc_us-gaap_SubsequentEventMember" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | </presentationLink> |
| <presentationLink xlink:type="extended" xlink:role="http://www.marinabiotech.com/role/StockholdersEquityDetails"> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_0"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_ClassOfWarrantOrRightOutstandingRollForward" xlink:label="loc_mrna_ClassOfWarrantOrRightOutstandingRollForward_1"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_mrna_ClassOfWarrantOrRightOutstandingRollForward_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_2"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_ClassOfWarrantOrRightOutstandingRollForward_1" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_ClassOfWarrantOrRightIssued" xlink:label="loc_mrna_ClassOfWarrantOrRightIssued_3"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_ClassOfWarrantOrRightOutstandingRollForward_1" xlink:to="loc_mrna_ClassOfWarrantOrRightIssued_3" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_ClassOfWarrantOrRightExercisedOrCancelled" xlink:label="loc_mrna_ClassOfWarrantOrRightExercisedOrCancelled_4"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_ClassOfWarrantOrRightOutstandingRollForward_1" xlink:to="loc_mrna_ClassOfWarrantOrRightExercisedOrCancelled_4" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_5"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_ClassOfWarrantOrRightOutstandingRollForward_1" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_5" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePriceRollForward" xlink:label="loc_mrna_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePriceRollForward_6"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_mrna_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePriceRollForward_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_WarrantsOutstandingWeightedAverageExercisePrice" xlink:label="loc_mrna_WarrantsOutstandingWeightedAverageExercisePrice_7"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePriceRollForward_6" xlink:to="loc_mrna_WarrantsOutstandingWeightedAverageExercisePrice_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_WarrantsIssuedWeightedAverageExercisePrice" xlink:label="loc_mrna_WarrantsIssuedWeightedAverageExercisePrice_8"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePriceRollForward_6" xlink:to="loc_mrna_WarrantsIssuedWeightedAverageExercisePrice_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_WarrantsExercisedOrCancelledWeightedAverageExercisePrice" xlink:label="loc_mrna_WarrantsExercisedOrCancelledWeightedAverageExercisePrice_9"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePriceRollForward_6" xlink:to="loc_mrna_WarrantsExercisedOrCancelledWeightedAverageExercisePrice_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_WarrantsOutstandingWeightedAverageExercisePrice" xlink:label="loc_mrna_WarrantsOutstandingWeightedAverageExercisePrice_10"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePriceRollForward_6" xlink:to="loc_mrna_WarrantsOutstandingWeightedAverageExercisePrice_10" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_ClassOfWarrantOrRightExpiringInNextTwelveMonths" xlink:label="loc_mrna_ClassOfWarrantOrRightExpiringInNextTwelveMonths_11"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_mrna_ClassOfWarrantOrRightExpiringInNextTwelveMonths_11" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_ClassOfWarrantOrRightExpiringInYearTwo" xlink:label="loc_mrna_ClassOfWarrantOrRightExpiringInYearTwo_12"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_mrna_ClassOfWarrantOrRightExpiringInYearTwo_12" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_ClassOfWarrantOrRightExpiringInYearThree" xlink:label="loc_mrna_ClassOfWarrantOrRightExpiringInYearThree_13"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_mrna_ClassOfWarrantOrRightExpiringInYearThree_13" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_ClassOfWarrantOrRightExpiringThereafter" xlink:label="loc_mrna_ClassOfWarrantOrRightExpiringThereafter_14"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_mrna_ClassOfWarrantOrRightExpiringThereafter_14" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | </presentationLink> |
| <presentationLink xlink:type="extended" xlink:role="http://www.marinabiotech.com/role/StockholdersEquityDetails1"> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_0"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_2"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_AwardTypeAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_SubscriptionUnitMember" xlink:label="loc_mrna_SubscriptionUnitMember_4"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3" xlink:to="loc_mrna_SubscriptionUnitMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_6"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_7"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_8"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_9"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_10"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_10" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceRollForward" xlink:label="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceRollForward_11"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5" xlink:to="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceRollForward_11" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePrice" xlink:label="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePrice_12"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceRollForward_11" xlink:to="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePrice_12" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised" xlink:label="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised_13"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceRollForward_11" xlink:to="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised_13" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExpired" xlink:label="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExpired_14"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceRollForward_11" xlink:to="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExpired_14" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePrice" xlink:label="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePrice_15"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceRollForward_11" xlink:to="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePrice_15" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/> |
| | </presentationLink> |
| <presentationLink xlink:type="extended" xlink:role="http://www.marinabiotech.com/role/StockholdersEquityPreferredStockDetails"> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_0"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_1"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_2"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1" xlink:to="loc_us-gaap_StatementClassOfStockAxis_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_3"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_2" xlink:to="loc_us-gaap_ClassOfStockDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_4"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_5"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="loc_us-gaap_SeriesCPreferredStockMember_6"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3" xlink:to="loc_us-gaap_SeriesCPreferredStockMember_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_PreferredStockPurchaseAgreementAxis" xlink:label="loc_mrna_PreferredStockPurchaseAgreementAxis_7"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1" xlink:to="loc_mrna_PreferredStockPurchaseAgreementAxis_7" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_PreferredStockPurchaseAgreementDomain" xlink:label="loc_mrna_PreferredStockPurchaseAgreementDomain_8"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_PreferredStockPurchaseAgreementAxis_7" xlink:to="loc_mrna_PreferredStockPurchaseAgreementDomain_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_PreferredStockPurchaseAgreementMember" xlink:label="loc_mrna_PreferredStockPurchaseAgreementMember_10"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_PreferredStockPurchaseAgreementDomain_8" xlink:to="loc_mrna_PreferredStockPurchaseAgreementMember_10" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaap_ClassOfStockLineItems_11"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1" xlink:to="loc_us-gaap_ClassOfStockLineItems_11" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_12"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_11" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_12" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_13"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_11" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_13" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_14"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_11" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_14" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_TermOfAgreement" xlink:label="loc_mrna_TermOfAgreement_15"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_11" xlink:to="loc_mrna_TermOfAgreement_15" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_PreferredStockValueOfSharesAvailableUnderPurchaseAgreement" xlink:label="loc_mrna_PreferredStockValueOfSharesAvailableUnderPurchaseAgreement_16"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_11" xlink:to="loc_mrna_PreferredStockValueOfSharesAvailableUnderPurchaseAgreement_16" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_17"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_11" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_17" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights_18"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_11" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights_18" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1" xlink:to="loc_us-gaap_SubsequentEventTypeAxis" order="30" use="optional"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="loc_us-gaap_SubsequentEventTypeDomain" order="0" use="optional"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="loc_us-gaap_SubsequentEventMember" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | </presentationLink> |
| <presentationLink xlink:type="extended" xlink:role="http://www.marinabiotech.com/role/StockholdersEquityCommonStockDetails"> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_0"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_StockholdersEquityNoteTable" xlink:label="loc_mrna_StockholdersEquityNoteTable_1"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_mrna_StockholdersEquityNoteTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_StockholdersEquityNoteAxis" xlink:label="loc_mrna_StockholdersEquityNoteAxis_2"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteTable_1" xlink:to="loc_mrna_StockholdersEquityNoteAxis_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_StockholdersEquityNoteDomain" xlink:label="loc_mrna_StockholdersEquityNoteDomain_3"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteAxis_2" xlink:to="loc_mrna_StockholdersEquityNoteDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_PublicOfferingOneMember" xlink:label="loc_mrna_PublicOfferingOneMember_4"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteDomain_3" xlink:to="loc_mrna_PublicOfferingOneMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_PublicOfferingTwoMember" xlink:label="loc_mrna_PublicOfferingTwoMember_5"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteDomain_3" xlink:to="loc_mrna_PublicOfferingTwoMember_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_PublicOfferingThreeMember" xlink:label="loc_mrna_PublicOfferingThreeMember_6"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteDomain_3" xlink:to="loc_mrna_PublicOfferingThreeMember_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_9"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteTable_1" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_10"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_9" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_10" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_SeriesAWarrantsMember" xlink:label="loc_mrna_SeriesAWarrantsMember_11"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_10" xlink:to="loc_mrna_SeriesAWarrantsMember_11" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_SeriesBWarrantsMember" xlink:label="loc_mrna_SeriesBWarrantsMember_12"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_10" xlink:to="loc_mrna_SeriesBWarrantsMember_12" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_LeaseTerminationAxis" xlink:label="loc_mrna_LeaseTerminationAxis_13"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteTable_1" xlink:to="loc_mrna_LeaseTerminationAxis_13" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_LeaseTerminationDomain" xlink:label="loc_mrna_LeaseTerminationDomain_14"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_LeaseTerminationAxis_13" xlink:to="loc_mrna_LeaseTerminationDomain_14" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_LeaseTerminationOneMember" xlink:label="loc_mrna_LeaseTerminationOneMember_15"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_LeaseTerminationDomain_14" xlink:to="loc_mrna_LeaseTerminationOneMember_15" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_StockPurchaseAgreementMember" xlink:label="loc_mrna_StockPurchaseAgreementMember_17"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_LeaseTerminationDomain_14" xlink:to="loc_mrna_StockPurchaseAgreementMember_17" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_18"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteTable_1" xlink:to="loc_dei_LegalEntityAxis_18" order="40" use="optional"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_19"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_18" xlink:to="loc_dei_EntityDomain_19" order="0" use="optional"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_NovosomAgMember" xlink:label="loc_mrna_NovosomAgMember_20"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_19" xlink:to="loc_mrna_NovosomAgMember_20" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_StockholdersEquityNoteLineItems" xlink:label="loc_mrna_StockholdersEquityNoteLineItems_21"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteTable_1" xlink:to="loc_mrna_StockholdersEquityNoteLineItems_21" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_22"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteLineItems_21" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_22" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_23"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteLineItems_21" xlink:to="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_23" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_NumberOfUnitsIssued" xlink:label="loc_mrna_NumberOfUnitsIssued_25"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteLineItems_21" xlink:to="loc_mrna_NumberOfUnitsIssued_25" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_NumberOfCommonSharesIssuedPerUnit" xlink:label="loc_mrna_NumberOfCommonSharesIssuedPerUnit_26"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteLineItems_21" xlink:to="loc_mrna_NumberOfCommonSharesIssuedPerUnit_26" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_NumberOfWarrantsIssuedPerUnit" xlink:label="loc_mrna_NumberOfWarrantsIssuedPerUnit_27"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteLineItems_21" xlink:to="loc_mrna_NumberOfWarrantsIssuedPerUnit_27" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_SalesPricePerShareOfCommonStock" xlink:label="loc_mrna_SalesPricePerShareOfCommonStock_28"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteLineItems_21" xlink:to="loc_mrna_SalesPricePerShareOfCommonStock_28" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_29"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteLineItems_21" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_29" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_StockIssuedDuringPeriodThroughWarrants" xlink:label="loc_mrna_StockIssuedDuringPeriodThroughWarrants_30"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteLineItems_21" xlink:to="loc_mrna_StockIssuedDuringPeriodThroughWarrants_30" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_ClassOfWarrantOrRightIssued" xlink:label="loc_mrna_ClassOfWarrantOrRightIssued_31"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteLineItems_21" xlink:to="loc_mrna_ClassOfWarrantOrRightIssued_31" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_32"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteLineItems_21" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_32" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_33"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteLineItems_21" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_33" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_NumberOfUnitsPurchasedPerSeriesbWarrants" xlink:label="loc_mrna_NumberOfUnitsPurchasedPerSeriesbWarrants_34"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteLineItems_21" xlink:to="loc_mrna_NumberOfUnitsPurchasedPerSeriesbWarrants_34" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_PurchasePricePerUnitPurchasedPerSeriesbWarrants" xlink:label="loc_mrna_PurchasePricePerUnitPurchasedPerSeriesbWarrants_35"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteLineItems_21" xlink:to="loc_mrna_PurchasePricePerUnitPurchasedPerSeriesbWarrants_35" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_NumberOfWarrantsExercised" xlink:label="loc_mrna_NumberOfWarrantsExercised_36"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteLineItems_21" xlink:to="loc_mrna_NumberOfWarrantsExercised_36" order="150" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_SharesIssuedForCashlessExercise" xlink:label="loc_mrna_SharesIssuedForCashlessExercise_37"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteLineItems_21" xlink:to="loc_mrna_SharesIssuedForCashlessExercise_37" order="160" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_PriceOfSharesIssuedForCashlessExercise" xlink:label="loc_mrna_PriceOfSharesIssuedForCashlessExercise_38"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteLineItems_21" xlink:to="loc_mrna_PriceOfSharesIssuedForCashlessExercise_38" order="170" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights_39"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteLineItems_21" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights_39" order="180" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_AdditionalNetProceedsFromSaleOfEquity" xlink:label="loc_mrna_AdditionalNetProceedsFromSaleOfEquity_40"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteLineItems_21" xlink:to="loc_mrna_AdditionalNetProceedsFromSaleOfEquity_40" order="200" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_ValueOfSharesIssuedToLandlord" xlink:label="loc_mrna_ValueOfSharesIssuedToLandlord_44"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteLineItems_21" xlink:to="loc_mrna_ValueOfSharesIssuedToLandlord_44" order="210" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_AmountOwnedFromVendors" xlink:label="loc_mrna_AmountOwnedFromVendors_45"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteLineItems_21" xlink:to="loc_mrna_AmountOwnedFromVendors_45" order="220" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_CommonStockSharesReserveForSettlementOfLoan" xlink:label="loc_mrna_CommonStockSharesReserveForSettlementOfLoan_46"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteLineItems_21" xlink:to="loc_mrna_CommonStockSharesReserveForSettlementOfLoan_46" order="230" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_OutstandingAmountOfLoanFromVendor" xlink:label="loc_mrna_OutstandingAmountOfLoanFromVendor_47"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteLineItems_21" xlink:to="loc_mrna_OutstandingAmountOfLoanFromVendor_47" order="240" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_SharesIssuedDuringPeriodForSettlementOfOutstandingAmountsDueToVendor" xlink:label="loc_mrna_SharesIssuedDuringPeriodForSettlementOfOutstandingAmountsDueToVendor_48"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteLineItems_21" xlink:to="loc_mrna_SharesIssuedDuringPeriodForSettlementOfOutstandingAmountsDueToVendor_48" order="250" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_ValueOfSharesIssuedDuringPeriodForSettlementOfOutstandingAmountsDueToVendor" xlink:label="loc_mrna_ValueOfSharesIssuedDuringPeriodForSettlementOfOutstandingAmountsDueToVendor_49"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteLineItems_21" xlink:to="loc_mrna_ValueOfSharesIssuedDuringPeriodForSettlementOfOutstandingAmountsDueToVendor_49" order="270" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_ValueOfCommonStockAgreedToPurchasedUnderAgreement" xlink:label="loc_mrna_ValueOfCommonStockAgreedToPurchasedUnderAgreement_51"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteLineItems_21" xlink:to="loc_mrna_ValueOfCommonStockAgreedToPurchasedUnderAgreement_51" order="280" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_DescriptionOfConsiderationForLicensedTechnology" xlink:label="loc_mrna_DescriptionOfConsiderationForLicensedTechnology_54"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteLineItems_21" xlink:to="loc_mrna_DescriptionOfConsiderationForLicensedTechnology_54" order="290" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_55"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteLineItems_21" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_55" order="300" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_CommitmentForFutureIssuanceOfShares" xlink:label="loc_mrna_CommitmentForFutureIssuanceOfShares_56"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteLineItems_21" xlink:to="loc_mrna_CommitmentForFutureIssuanceOfShares_56" order="320" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_IssuanceOfImmediatelyVestedRestrictedCommonStock" xlink:label="loc_mrna_IssuanceOfImmediatelyVestedRestrictedCommonStock_57"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteLineItems_21" xlink:to="loc_mrna_IssuanceOfImmediatelyVestedRestrictedCommonStock_57" order="330" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_CompensationCharge" xlink:label="loc_mrna_CompensationCharge_58"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteLineItems_21" xlink:to="loc_mrna_CompensationCharge_58" order="340" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_TotalSharesIssuedUnderPurchaseAgreementPriorToTermination" xlink:label="loc_mrna_TotalSharesIssuedUnderPurchaseAgreementPriorToTermination_62"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteLineItems_21" xlink:to="loc_mrna_TotalSharesIssuedUnderPurchaseAgreementPriorToTermination_62" order="350" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockVotingRights" xlink:label="loc_us-gaap_CommonStockVotingRights"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteLineItems_21" xlink:to="loc_us-gaap_CommonStockVotingRights" order="370" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_SharesIssuedUnderPurchaseAgreementPriorToTerminationValue" xlink:label="loc_mrna_SharesIssuedUnderPurchaseAgreementPriorToTerminationValue"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteLineItems_21" xlink:to="loc_mrna_SharesIssuedUnderPurchaseAgreementPriorToTerminationValue" order="360" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteLineItems_21" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" order="380" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteTable_1" xlink:to="loc_us-gaap_SubsequentEventTypeAxis" order="50" use="optional"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="loc_us-gaap_SubsequentEventTypeDomain" order="0" use="optional"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="loc_us-gaap_SubsequentEventMember" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_SharesToBeIssuedDuringPeriodForSettlementOfOutstandingAmountsDueToVendor" xlink:label="loc_mrna_SharesToBeIssuedDuringPeriodForSettlementOfOutstandingAmountsDueToVendor"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteLineItems_21" xlink:to="loc_mrna_SharesToBeIssuedDuringPeriodForSettlementOfOutstandingAmountsDueToVendor" order="260" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteLineItems_21" xlink:to="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" order="310" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_FairValueOfSharesToBeIssued" xlink:label="loc_mrna_FairValueOfSharesToBeIssued"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteLineItems_21" xlink:to="loc_mrna_FairValueOfSharesToBeIssued" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_ReclassificationOfFairValueLiabilityForPriceAdjustableWarrantsExercised" xlink:label="loc_mrna_ReclassificationOfFairValueLiabilityForPriceAdjustableWarrantsExercised"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteLineItems_21" xlink:to="loc_mrna_ReclassificationOfFairValueLiabilityForPriceAdjustableWarrantsExercised" order="190" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_SharesToBeIssuedDuringPeriodForSettlementOfAmountsDueToEmployementAgreementAndAccruedManagementFees" xlink:label="loc_mrna_SharesToBeIssuedDuringPeriodForSettlementOfAmountsDueToEmployementAgreementAndAccruedManagementFees"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteLineItems_21" xlink:to="loc_mrna_SharesToBeIssuedDuringPeriodForSettlementOfAmountsDueToEmployementAgreementAndAccruedManagementFees" order="390" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | </presentationLink> |
| <presentationLink xlink:type="extended" xlink:role="http://www.marinabiotech.com/role/StockholdersEquityWarrantsDetails"> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_0"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_StockholdersEquityNoteTable" xlink:label="loc_mrna_StockholdersEquityNoteTable_1"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_mrna_StockholdersEquityNoteTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_StockholdersEquityNoteAxis" xlink:label="loc_mrna_StockholdersEquityNoteAxis_2"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteTable_1" xlink:to="loc_mrna_StockholdersEquityNoteAxis_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_StockholdersEquityNoteDomain" xlink:label="loc_mrna_StockholdersEquityNoteDomain_3"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteAxis_2" xlink:to="loc_mrna_StockholdersEquityNoteDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_PublicOfferingOneMember" xlink:label="loc_mrna_PublicOfferingOneMember_4"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteDomain_3" xlink:to="loc_mrna_PublicOfferingOneMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_PublicOfferingTwoMember" xlink:label="loc_mrna_PublicOfferingTwoMember_5"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteDomain_3" xlink:to="loc_mrna_PublicOfferingTwoMember_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_AmendedNoteAndWarrantPurchaseAgreementMember" xlink:label="loc_mrna_AmendedNoteAndWarrantPurchaseAgreementMember_6"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteDomain_3" xlink:to="loc_mrna_AmendedNoteAndWarrantPurchaseAgreementMember_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_7"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteTable_1" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_7" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_8"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_7" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_SeriesAWarrantsMember" xlink:label="loc_mrna_SeriesAWarrantsMember_9"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_8" xlink:to="loc_mrna_SeriesAWarrantsMember_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_SeriesBWarrantsMember" xlink:label="loc_mrna_SeriesBWarrantsMember_10"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_8" xlink:to="loc_mrna_SeriesBWarrantsMember_10" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_StockholdersEquityNoteLineItems" xlink:label="loc_mrna_StockholdersEquityNoteLineItems_11"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteTable_1" xlink:to="loc_mrna_StockholdersEquityNoteLineItems_11" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_StockIssuedDuringPeriodThroughWarrants" xlink:label="loc_mrna_StockIssuedDuringPeriodThroughWarrants_12"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteLineItems_11" xlink:to="loc_mrna_StockIssuedDuringPeriodThroughWarrants_12" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_SalesPricePerShareOfCommonStock" xlink:label="loc_mrna_SalesPricePerShareOfCommonStock_13"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteLineItems_11" xlink:to="loc_mrna_SalesPricePerShareOfCommonStock_13" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_ClassOfWarrantOrRightIssued" xlink:label="loc_mrna_ClassOfWarrantOrRightIssued_14"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteLineItems_11" xlink:to="loc_mrna_ClassOfWarrantOrRightIssued_14" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights_15"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteLineItems_11" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights_15" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_NumberOfWarrantsExercised" xlink:label="loc_mrna_NumberOfWarrantsExercised_16"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteLineItems_11" xlink:to="loc_mrna_NumberOfWarrantsExercised_16" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_17"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteLineItems_11" xlink:to="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_17" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_AdjustmentToEquityDueToChangeInExercisePriceOfWarrants" xlink:label="loc_mrna_AdjustmentToEquityDueToChangeInExercisePriceOfWarrants_19"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteLineItems_11" xlink:to="loc_mrna_AdjustmentToEquityDueToChangeInExercisePriceOfWarrants_19" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_NumberOfWarrantsExpired" xlink:label="loc_mrna_NumberOfWarrantsExpired_20"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteLineItems_11" xlink:to="loc_mrna_NumberOfWarrantsExpired_20" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_ProceedsFromIssuanceOfNotesPayableAndWarrantsGross" xlink:label="loc_mrna_ProceedsFromIssuanceOfNotesPayableAndWarrantsGross_21"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteLineItems_11" xlink:to="loc_mrna_ProceedsFromIssuanceOfNotesPayableAndWarrantsGross_21" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteLineItems_11" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteTable_1" xlink:to="loc_us-gaap_DebtInstrumentAxis" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="loc_us-gaap_DebtInstrumentNameDomain" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteTable_1" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="loc_us-gaap_DerivativeContractTypeDomain" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PriceRiskDerivativeMember" xlink:label="loc_us-gaap_PriceRiskDerivativeMember"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="loc_us-gaap_PriceRiskDerivativeMember" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_FairValueOfWarrantsIssuedStockPrice" xlink:label="loc_mrna_FairValueOfWarrantsIssuedStockPrice"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteLineItems_11" xlink:to="loc_mrna_FairValueOfWarrantsIssuedStockPrice" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteLineItems_11" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_WarrantsVestingPeriod" xlink:label="loc_mrna_WarrantsVestingPeriod"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteLineItems_11" xlink:to="loc_mrna_WarrantsVestingPeriod" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteTable_1" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaap_RelatedPartyDomain" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_ConsultantMember" xlink:label="loc_mrna_ConsultantMember"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="loc_mrna_ConsultantMember" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_8" xlink:to="loc_us-gaap_WarrantMember" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_StockholdersEquityNoteTable_1" xlink:to="loc_us-gaap_SubsequentEventTypeAxis" order="60" use="optional"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="loc_us-gaap_SubsequentEventTypeDomain" order="0" use="optional"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="loc_us-gaap_SubsequentEventMember" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_PlacementAgentMember" xlink:label="loc_mrna_PlacementAgentMember"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="loc_mrna_PlacementAgentMember" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | </presentationLink> |
| <presentationLink xlink:type="extended" xlink:role="http://www.marinabiotech.com/role/StockholdersEquitySubscriptionInvestmentUnitsDetails"> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_0"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_SharesAvailableForPurchaseSubscriptionInvestmentUnits" xlink:label="loc_mrna_SharesAvailableForPurchaseSubscriptionInvestmentUnits_1"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_mrna_SharesAvailableForPurchaseSubscriptionInvestmentUnits_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_PerSharePriceForSharesAvailableForPurchaseSubscriptionInvestmentUnits" xlink:label="loc_mrna_PerSharePriceForSharesAvailableForPurchaseSubscriptionInvestmentUnits_2"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_mrna_PerSharePriceForSharesAvailableForPurchaseSubscriptionInvestmentUnits_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_DescriptionOfSubscriptionInvestmentUnits" xlink:label="loc_mrna_DescriptionOfSubscriptionInvestmentUnits_3"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_mrna_DescriptionOfSubscriptionInvestmentUnits_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | </presentationLink> |
| <presentationLink xlink:type="extended" xlink:role="http://www.marinabiotech.com/role/StockIncentivePlansDetailTextuals"> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_2"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_PlanNameAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_3"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_2" xlink:to="loc_us-gaap_PlanNameDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_CequentStockIncentive2006PlanMember" xlink:label="loc_mrna_CequentStockIncentive2006PlanMember_4"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_3" xlink:to="loc_mrna_CequentStockIncentive2006PlanMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_5"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_CequentPharmaceuticalsIncMember" xlink:label="loc_mrna_CequentPharmaceuticalsIncMember_7"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6" xlink:to="loc_mrna_CequentPharmaceuticalsIncMember_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_8"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_AwardTypeAxis_8" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaap_RestrictedStockMember_10"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9" xlink:to="loc_us-gaap_RestrictedStockMember_10" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_15"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_15" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_16"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_16" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_17"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_17" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_18"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_18" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_19"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_19" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_20"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_20" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_21"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_21" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_22"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_22" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_23"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_23" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_24"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_24" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_25"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_25" order="150" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance_26"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance_26" order="160" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_27"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_27" order="170" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_29"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_29" order="180" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_StockIncentivePlan2008Member" xlink:label="loc_mrna_StockIncentivePlan2008Member"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_3" xlink:to="loc_mrna_StockIncentivePlan2008Member" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_EmployeeStockPurchasePlanMember" xlink:label="loc_mrna_EmployeeStockPurchasePlanMember"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_3" xlink:to="loc_mrna_EmployeeStockPurchasePlanMember" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_NumberOfBoardOfDirectorsRetired" xlink:label="loc_mrna_NumberOfBoardOfDirectorsRetired"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14" xlink:to="loc_mrna_NumberOfBoardOfDirectorsRetired" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePeriodExtend" xlink:label="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePeriodExtend"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14" xlink:to="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePeriodExtend" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | </presentationLink> |
| <presentationLink xlink:type="extended" xlink:role="http://www.marinabiotech.com/role/StockIncentivePlansStockBasedCompensationExpenseDetails"> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_2"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_3"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_2" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_4"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_3" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_6"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_7"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_6" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_3" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | </presentationLink> |
| <presentationLink xlink:type="extended" xlink:role="http://www.marinabiotech.com/role/StockIncentivePlansStockOptionActivityDetails"> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_4"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_4" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_5"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_5" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_6"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_6" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_7"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_7" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_8"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_9"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_9" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_10"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_10" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_11"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_11" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_12"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_12" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | </presentationLink> |
| <presentationLink xlink:type="extended" xlink:role="http://www.marinabiotech.com/role/StockIncentivePlansStockOptionsOutstandingDetails"> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_2"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_AwardTypeAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_4"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3" xlink:to="loc_us-gaap_EmployeeStockOptionMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_5"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_6"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_5" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_ExercisePriceRangeDollarTwoToDollarTwoPointTwoZeroMember" xlink:label="loc_mrna_ExercisePriceRangeDollarTwoToDollarTwoPointTwoZeroMember_7"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_6" xlink:to="loc_mrna_ExercisePriceRangeDollarTwoToDollarTwoPointTwoZeroMember_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_ExercisePriceRangeDollarElevenPointSixZeroToDollarFiftyMember" xlink:label="loc_mrna_ExercisePriceRangeDollarElevenPointSixZeroToDollarFiftyMember_8"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_6" xlink:to="loc_mrna_ExercisePriceRangeDollarElevenPointSixZeroToDollarFiftyMember_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_ExercisePriceRangeDollarFiftyOneToDollarNinetyPointEightZeroMember" xlink:label="loc_mrna_ExercisePriceRangeDollarFiftyOneToDollarNinetyPointEightZeroMember_9"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_6" xlink:to="loc_mrna_ExercisePriceRangeDollarFiftyOneToDollarNinetyPointEightZeroMember_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_ExercisePriceRangeDollarOneHundredAndTwentySevenPointSixZeroToDollarTwoHundredAndSevenPointSixZeroMember" xlink:label="loc_mrna_ExercisePriceRangeDollarOneHundredAndTwentySevenPointSixZeroToDollarTwoHundredAndSevenPointSixZeroMember_10"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_6" xlink:to="loc_mrna_ExercisePriceRangeDollarOneHundredAndTwentySevenPointSixZeroToDollarTwoHundredAndSevenPointSixZeroMember_10" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_ExercisePriceRangeDollarFourHundredAndTwentyToDollarFiveHundredAndEightyEightPointEightZeroMember" xlink:label="loc_mrna_ExercisePriceRangeDollarFourHundredAndTwentyToDollarFiveHundredAndEightyEightPointEightZeroMember_11"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_6" xlink:to="loc_mrna_ExercisePriceRangeDollarFourHundredAndTwentyToDollarFiveHundredAndEightyEightPointEightZeroMember_11" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_12"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_12" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_13"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_12" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_13" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_14"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_12" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_14" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_15"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_12" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_15" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_16"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_12" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_16" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_17"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_12" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_17" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_18"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_12" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_18" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_19"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_12" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_19" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_20"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_12" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_20" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | </presentationLink> |
| <presentationLink xlink:type="extended" xlink:role="http://www.marinabiotech.com/role/StockIncentivePlansWeightedAverageAssumptionsDetails"> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_1"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_1" order="13" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | </presentationLink> |
| <presentationLink xlink:type="extended" xlink:role="http://www.marinabiotech.com/role/EmployeeBenefitPlanDetailTextuals"> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_0"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:label="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_1"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_0" xlink:to="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | </presentationLink> |
| <presentationLink xlink:type="extended" xlink:role="http://www.marinabiotech.com/role/IncomeTaxesDetails"> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsNetAbstract" xlink:label="loc_us-gaap_DeferredTaxAssetsNetAbstract_1"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_DeferredTaxAssetsNetAbstract_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_2"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_1" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_3"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_1" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_3" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:label="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_4"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_1" xlink:to="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_4" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_5"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_1" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_5" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_6"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_1" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_6" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_7"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_1" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_7" order="50" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_8"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_1" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_8" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract_9"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract_9" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_10"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract_9" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_10" order="0" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_11"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract_9" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_11" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/> |
| | </presentationLink> |
| <presentationLink xlink:type="extended" xlink:role="http://www.marinabiotech.com/role/IncomeTaxesDetailTextuals"> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_FederalOperatingLossCarryforwards" xlink:label="loc_mrna_FederalOperatingLossCarryforwards"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_mrna_FederalOperatingLossCarryforwards" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_StateOperatingLossCarryforwards" xlink:label="loc_mrna_StateOperatingLossCarryforwards"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_mrna_StateOperatingLossCarryforwards" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | </presentationLink> |
| <presentationLink xlink:type="extended" xlink:role="http://www.marinabiotech.com/role/CommitmentsAndContingenciesDetails"> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_CommitmentsAndContingenciesTable" xlink:label="loc_mrna_CommitmentsAndContingenciesTable_1"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0" xlink:to="loc_mrna_CommitmentsAndContingenciesTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_2"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_CommitmentsAndContingenciesTable_1" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_3"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_2" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LetterOfCreditMember" xlink:label="loc_us-gaap_LetterOfCreditMember_4"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_3" xlink:to="loc_us-gaap_LetterOfCreditMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_5"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_CommitmentsAndContingenciesTable_1" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_6"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_5" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_7"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_6" xlink:to="loc_us-gaap_SubsequentEventMember_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_CommitmentsAndContingenciesLineItems" xlink:label="loc_mrna_CommitmentsAndContingenciesLineItems_8"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_CommitmentsAndContingenciesTable_1" xlink:to="loc_mrna_CommitmentsAndContingenciesLineItems_8" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_AmountDrawnFromLetterOfCredit" xlink:label="loc_mrna_AmountDrawnFromLetterOfCredit_9"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_CommitmentsAndContingenciesLineItems_8" xlink:to="loc_mrna_AmountDrawnFromLetterOfCredit_9" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_StandbyLetterOfCreditMaximumLiability" xlink:label="loc_mrna_StandbyLetterOfCreditMaximumLiability_10"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_CommitmentsAndContingenciesLineItems_8" xlink:to="loc_mrna_StandbyLetterOfCreditMaximumLiability_10" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LeaseAndRentalExpense" xlink:label="loc_us-gaap_LeaseAndRentalExpense_12"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_CommitmentsAndContingenciesLineItems_8" xlink:to="loc_us-gaap_LeaseAndRentalExpense_12" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RestructuringReservePeriodIncreaseDecrease" xlink:label="loc_us-gaap_RestructuringReservePeriodIncreaseDecrease_13"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_CommitmentsAndContingenciesLineItems_8" xlink:to="loc_us-gaap_RestructuringReservePeriodIncreaseDecrease_13" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | <loc xlink:type="locator" xlink:href="mrna-20121231.xsd#mrna_CommonStockCommittedToBeIssued" xlink:label="loc_mrna_CommonStockCommittedToBeIssued"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_CommitmentsAndContingenciesLineItems_8" xlink:to="loc_mrna_CommonStockCommittedToBeIssued" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | </presentationLink> |
| <roleRef xlink:type="simple" xlink:href="mrna-20121231.xsd#SubsequentEvents" roleURI="http://www.marinabiotech.com/role/SubsequentEvents"/> |
| <presentationLink xlink:type="extended" xlink:role="http://www.marinabiotech.com/role/SubsequentEvents"> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaap_SubsequentEventsAbstract"/> |
| | <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaap_SubsequentEventsTextBlock"/> |
| | <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="loc_us-gaap_SubsequentEventsTextBlock" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> |
| | </presentationLink> |
| </linkbase> |